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ABSTRACT 
A clinical trial is a study that assesses the effectiveness and safety of a new drug or treatment. 
To be able to generalize from the findings of the study, the clinical trial requires a 
representative sample of the target patient population. The target population is defined in 
terms of eligibility criteria that clearly describe the characteristics of patients enrolled in the 
study. The eligibility criteria are stated in natural language in its own section in a protocol 
document, which serves as the plan and detailed description of any prospective clinical trial. 
Having the eligibility criteria expressed as natural language has several drawbacks. First, it 
can lead to ambiguities and different interpretations among clinicians responsible for 
enrolment of patients into the study, which consequently may affect the safety of patients. 
Second, it provides no means of automatic eligibility checking against patient databases and 
electronic patient journals. The process of determining the eligibility of each patient therefore 
becomes a resource demanding and time consuming task. Formally defined computer 
interpretable eligibility criteria could potentially improve safety of involved patients and 
efficiency in patient enrolment. This thesis presents the Eligibility Criteria Builder that aims 
to provide a simple and pragmatic way of defining these rules using a user-friendly graphical 
user interface. The evaluation of the prototype indicated that the target users in general were 
positive to, and clearly saw the need for, a tool like this.  The evaluation also pointed out 
weak spots and areas of improvements for the proposed prototype. 
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1 INTRODUCTION 
A clinical trial is a study that assesses the effectiveness and safety of a new drug or treatment. 
To be able to generalize from the findings of the study, the clinical trial requires a 
representative sample of the target patient population. The target population is defined in 
terms of eligibility criteria that clearly describe the characteristics of patients enrolled in the 
study. In current clinical trials, the eligibility criteria are stated in natural language in its own 
section in a protocol document, which serves as the plan and detailed description of the 
prospective clinical trial. Natural language opens for ambiguities and different interpretations 
among clinical researchers. This is illustrated in an example by Chow & Liu (2004, pp. 611-
612), where they refer to a protocol having an inclusion criterion that requires patients 
between 18 and 65 years of age without being clear on whether or not patients of 18 years of 
age would be considered eligible. If the eligibility criteria in a clinical trial are vague and 
ambiguous, it can potentially have serious impact on the safety of involved patients (i.e. the 
risk of including an ineligible patient due to misinterpretation). Furthermore, it directly 
affects both the external validity (generalizability) and reproducibility (i.e. the likelihood of 
arriving at the same findings in another, similar future trial Chow & Liu (2004)) of the 
findings of a clinical study. 
When recruiting patients in a clinical trial that requires an estimated two-thousand subjects, 
the initial group of potential subjects may be multiple times larger in order to find the two-
thousand that fulfil the eligibility criteria (for rare diseases the number may reach 10 000). 
The eligibility of each potential subject must be assessed by a qualified clinician. The 
information needed to assure the eligibility may be available from different sources like paper 
based patient journals, patient databases, lab tests or case report forms. For each patient, a 
clinician must look up information found in these different sources to verify that all inclusion 
criteria are met by the patient. For each exclusion criterion, the same task is repeated, to 
ensure that none of the exclusion criteria are met. Only after such thorough investigations can 
the patient be determined as eligible for participation and be enrolled into the clinical trial. 
Thus, the process of manually determining the eligibility of thousands of potential eligible 
patients becomes a resource demanding and time consuming task. 
Having the eligibility criteria expressed in natural language also has other potential 
drawbacks. First, it can lead to ambiguities and different interpretations among clinicians 
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responsible for enrolment of patients into the study, which consequently may affect the safety 
of patients. Second, it provides no means of automatic eligibility checking against patient 
databases and electronic patient journals. So, in addition to being a time consuming task that 
requires a lot of resources, manual eligibility determination may also, at worst, affect the 
validity of the findings and the safety of patients involved in the study. Accordingly, formally 
defined computer interpretable eligibility criteria could potentially improve both the safety of 
involved patients and efficiency in patient enrolment. 
Enrolled participants can be classified as ineligible at any stage in an ongoing clinical trial if 
their medical condition changes. Also, changes in the medical state of former ineligible 
participants can result in a change in the participant eligibility classification. In the former, it 
is of particular importance that clinical trial staff is informed about the change in eligibility 
status. Similarly, in the latter, it can be of considerable value to enrol these eligible 
“newcomers” as participants in the study. 
Further, being able to express the rules for eligibility in direct conjunction with how the 
collected patient data will be stored in the ongoing study will give way for validity checks of 
enrolled patients, and could also enable monitoring of change in any patient-characteristics 
that may influence eligibility status. 
Utilization of computer interpretable eligibility criteria would, however, require the needed 
information to be available from digitalized sources like electronic patient journals, electronic 
case report forms and digital lab-tests. As this is the goal of the OMEVAC project (see own 
description in 1.1), this thesis fits into the vision of a future where these digital resources will 
be available. 
Within the frame of the OMEVAC project, a prototype has been developed to explore the 
possibility of providing an interface for stating eligibility criteria in an unambiguous 
machine-interpretable fashion as opposed to the current practice of expressing these criteria 
in natural language. This thesis presents the Eligibility Criteria Builder that aims at providing 
a simple and pragmatic way of defining these rules using a user-friendly graphical user 
interface. The evaluation of the prototype showed that the target users in general were 
positive to, and clearly saw the need for, a system like this.  However, the evaluation also 
pointed out weak spots and areas of improvements for the proposed prototype. 
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1.1 The OMEVAC project 
This thesis is a part of the OMEVAC project (Open Mobile Electronic Vaccine Trials) which 
is funded by the Norwegian Research Council (NFR). OMEVAC is led by the Centre for 
International Health (CIH), an interfaculty institution at the University of Bergen. One of the 
stated goals of the OMEVAC project is to move from a paper-based way of conducting 
clinical trials to exploit the possibilities given by computers and electronic capture devices. 
One of the achievements will be patient databases and electronic medical records. This 
prospect paves the way for automatic patient selection based on computerized eligibility 
criteria. 
The Eligibility Criteria Builder prototype and the findings of this study will be a contribution 
to the OMEVAC project intended to support and improve the conduct of clinical trials in the 
developing world. 
1.2 Target users 
Formulating eligibility criteria requires knowledge about the diagnosis towards which the 
intervention is directed, any biochemical properties and compatibility of the intervention 
(known adverse reactions) and patient characteristics. For instance, some patients may have 
hypersensitivity or fatal adverse reactions to a drug. Obviously, these patients should not be 
exposed to it, and they should therefore never be included in the study. 
The users of such a system are those responsible for administering and planning the execution 
of a clinical trial. The prototype must be easy to use and should not require the user to have 
programming skills, but at the same time be flexible enough to suit a wide range of different 
clinical trials. This means that the prototype must be data-model independent in order to able 
to cover the multitude of different properties that different clinical trials might have. 
1.3 Research question 
The aim of this project is to explore the feasibility of using a more programmatic, and thus 
formal, way of expressing inclusion and exclusion criteria for planned clinical trials. In order 
to be able to achieve this, a prototype of a web based application has been iteratively 
developed and evaluated. 
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The guiding research question for this project is:  
How can a data model independent software tool be developed to support users to formally 
define criteria for patient eligibility in a clinical trial? 
1.4 Terms  
In this thesis, the terms “tool”, “system” and “prototype” are all used interchangeable to 
describe the Eligibility Criteria Builder. 
1.4.1 Clinical trial 
A clinical trial can be defined in many ways. Friedman, Furberg, & DeMets (1996, p. 2) 
define a clinical trial as ”(…) a prospective study comparing the effect and value of 
intervention(s) against a control in human beings”. Piantadosi (1997) provided a simpler 
definition of a clinical trial as “an experimental testing of a medical treatment on human 
subjects” (quoted in Chow & Liu, 2004, p. 1). The characteristics of a clinical trial are 
described more in depth in section 2.1. 
1.4.2 Study protocol 
The study protocol is the document that details how a clinical trial is to be carried out and 
how the data are to be collected and analyzed (Chow & Liu, 2004). A widely adopted 
definition is provided by the International Conference on Harmonization (ICH) of Technical 
Requirements for Registration of Pharmaceuticals for Human Use: “a document that 
describes the objective(s), design, methodology, statistical considerations and organizations 
of a trial.” (May, 1996, p. 6). 
1.4.3 Eligibility Criteria 
Eligibility criteria are defined in a separate paragraph in the study protocol. It is a list of 
requirements that a person must meet in order to be determined as eligible for enrolment into 
a clinical trial. “These criteria include demographic characteristics, prior or current diagnoses, 
laboratory-test results, subjective symptoms, physical findings, current or prior medications, 
and drug allergies” (Tu, Kemper, Lane, Carlson, & Musen, 1993, p. 341). 
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1.4.4 Inclusion Criteria 
Inclusion criteria are a list of requirements that a patient must meet in order to be enrolled in 
a study. A patient must meet all inclusion criteria in order to be considered eligible. 
1.4.5 Exclusion Criteria 
The exclusion criteria are conditions that would disqualify the patient for enrolment in the 
study (i.e. known hypersensitivity to the proposed drug or treatment). A patient who meets 
any of the exclusion criteria will be considered ineligible for enrolment. 
1.4.6 Patient recruitment 
Patient recruitment refers to the process of recruiting patients to a clinical trial. This can be 
done by advertising in media, querying a large database to find potentially qualified people, 
or by medical practitioners reporting. 
1.4.7 Patient enrolment 
This is the activity of enrolling patients to an ongoing study. In order to be enrolled, a patient 
must meet the eligibility criteria. 
1.4.8 Eligibility checking 
Eligibility checking is the process of determining whether a patient meets the eligibility 
criteria. 
1.5 Structure of the thesis 
As this chapter has given an introduction to the project and its background, chapter two gives 
a more in-depth description of its context and other related approaches that utilize 
information technology in supporting the conduct of clinical trials. In particular other 
attempts that aim to formalize the study protocol, or crucial parts of it, are described. Chapter 
three provides discussion of the methodological approaches employed in this thesis, both in 
terms of research methodology and development methodology. In chapter four, the 
development process is described, together with a presentation of the resulting prototype. 
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Chapter five describes the evaluation design and presents the findings along with a discussion 
of their implications. Chapter six reviews and concludes the project and suggests ideas for 
future work. 
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2 RELATED WORK  
This chapter presents a more in-depth description of a clinical trial and related approaches 
that utilize information technology in supporting the conduct of clinical trials. 
2.1 What is a clinical trial? 
A clinical trial is often understood as testing the effects of a drug, but the term can be 
broadened to include almost any type of intervention meant to improve human health, like 
running an attitude campaign to increase awareness about HIV/AIDS, or introducing 
mosquito nets as a means to prevent the spread of malaria. It is the fundamental activity of 
finding the answer to the question “Does the treatment work as intended?” In order to answer 
that question, a thorough study has to be carried out, usually involving a control group 
receiving placebo or most effective alternative treatment, as well as precise monitoring of the 
medical condition of involved patients. 
Clinical trials are classified in four phases from I to IV (Chow & Liu, 2004; Friedman, et al., 
1996). In the first phase (Phase I study), the treatment is usually tested for the first time on a 
very small group of healthy patients. The goal of a Phase I trial is to assess the safety of the 
treatment (i.e. determine a safe dosage and discover possible side-effects). Phase II trials 
involve a somewhat larger group of subjects (100 - 300). As in phase I studies, the goal is to 
assess the safety of the treatment and discover side-effects, but in addition, phase II trials also 
try to answer how well the treatment works. A Phase III trial is a comprehensive study 
administered to a significantly larger patient group (> 1000). After a treatment has passed a 
Phase III trial, it is authorised for prescription and approved for sale. The treatment will 
however continue to be monitored in long-term Phase IV trials. Because phase I-III studies 
are conducted over a shorter time span, the possible long-term side effects of the treatment 
cannot be fully known in these phases. Phase IV trials therefore continue to collect data about 
the treatment, to further assess its safety, effects and effectiveness.  
All the clinical trial phases need subjects who meet the eligibility criteria. Each trial phase 
starts with a preparatory stage in which patients are recruited, eligibility status checked, and 
then enrolled (given they are determined as eligible). 
Figure 1: The recruitment and enrolment steps in the preparatory stage of a clinical t
The process of finding people who are 
in three main steps (Figure 1). First, a group of potentially qualified 
candidates for participation. The recruitment process typically involves contacting hospitals, 
advertising in media or querying a patient database to look for patients that may be 
considered candidates. Then, a more careful analysis of each patient’s eligibility for the given 
study is performed by a study manager. If a patient does not meet the eligibility criteria, 
enrolment of the patient is cancelled.
A formalization of eligibility criter
eligibility determination stage. If a large database of patient data and patients’ medical history
is available, formal eligibility criteria can be used to 
eligibility criteria determination stage, formal eligibility criteria may not be used alone to 
determine a patients eligibility, but rather as an indicator that guides the study manager into 
making a qualified decision on whether to enrol the patient or not
2.2 Clinical Trials Information Systems (CTIS)
A clinical trial information system (CTIS
conduct of a clinical trial. According to Oliveira & Salgado 
understood as multi-modular systems because of the multiplicity and heterogeneity of the
tasks that are part of the clinical trials cycle”. The authors describe protocol authoring tools 
and patient eligibility determination tools as examples of active research areas that falls 
within this understanding of a CTIS. Most commercial systems today
                                                
1
 Sometimes referred to as Clinical Trials Management System (CTMS)
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described as Clinical Study Data Management Systems (CSDMSs), because they are 
“essentially concerned with the delivery of valid and accurate data in conformity with the 
Good Clinical Practice (GCP) guidelines” (Oliveira & Salgado, 2006, p. 386). The focus on 
data management, as opposed to clinical trial management in a wider, organizational sense is 
a noteworthy difference between a CSDMS and a CTIS. 
Even though clinical trial software exists, the existing systems are either based on proprietary 
data formats, forcing the clinical researchers to use (often expensive) software from a specific 
vendor or require highly experienced technical personnel (i.e. require consultants from the 
vendor itself) to operate.  OpenClinica is an example of a feature-rich open source CTIS that 
supports management of all stages in a clinical trial, but it support any means of defining 
formal eligibility criteria. OpenMRS is an open source medical record system targeted for the 
developing world. It is implemented and used in production settings in several African 
countries today. However, it is not classified as a clinical trial management system, and offers 
no protocol authoring features. OpenMRS includes a cohort builder to select patients based 
on different criteria, which will be given more attention in section 2.6. 
2.3 Protocol representation 
Clinical Data Interchange Standards Consortium (CDISC) is a global, open, 
multidisciplinary, non-profit organization that has established standards to support the 
acquisition, exchange, submission and archive of clinical research data and metadata2. 
CDISC leads the Biomedical Research Integrated Domain Group (BRIDG) project, which is 
a collaborative initiative between different health research organizations that brings together 
different standards communities to clarify the semantics of clinical research across 
pharmaceutical, regulatory and research organizations (Fridsma, Evans, Hastak, & Mead, 
2007, p. 130). Its main goal is harmonization of different standards of clinical data to provide 
interoperability and establish a shared semantic understanding in order to enable exchanging, 
sharing and systematic analysis and integration of clinical trials data (Fridsma, et al., 2007). 
The output of the project is the BRIDG model, which merges different standards through the 
process of harmonization. 
                                               
2
 http://www.cdisc.org/about/index.html, Accessed May 29, 2009 
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A subgroup of BRIDG, the Protocol Representation (PR) group works on developing a 
standard structured protocol representation so that protocol information can be repurposed 
across multiple clinical research documents, databases, and systems from study start-up 
through reporting and regulatory submissions (Willoughby, et al., 2007). The PR group aims 
at creating a structured representation of inclusion/exclusion criteria part of the protocol 
(Willoughby, et al., 2007).  
The BRIDG model presupposes that the eligibility criteria check is carried out by a clinician 
and does not support any way of assisting the selection of valid subjects. Whether a patient is 
to be selected or not is stored as an integrated part of the BRIDG data model, represented by 
the “PerformedEligibilityCriterion” class. This class has a “questionCode” attribute which 
points to a coded question (i.e. “Is the subject at least 18 years old?”) and a Boolean (yes/no) 
“requiredAnswer” attribute (see Figure 2). This means, however, that information that might 
already be recorded with the system will not be re-used at the time of the actual patient 
selection. If the patient is already registered in the database, its age information is most likely 
also stored. So the answer to this question actually represents redundancy as the same 
information could be retrieved using the condition “patient.age >= 18”. 
 
Figure 2: How the BRIDG model represents eligibility criteria (BRIDG Release 2.1, p. 59) 3  
At the time of writing, no concrete proposal exists on how a structured representation of 
eligibility criteria that re-uses data that may already be collected, can be achieved. The 
Eligibility Criteria Builder may constitute such a proposal. 
                                               
3
 Excerpt from the Static Elements Report.rtf file in BRIDG_Release_2.1_Package.zip, 
downloadable from http://gforge.nci.nih.gov/frs/?group_id=342 
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2.4 Patient selection 
As most commercial systems focus on the data management part of clinical trials, few of 
them tend to incorporate additional features to automate complex procedures that 
traditionally are done manually by a clinician. Oliveira & Salgado claims that “More 
advanced features like patient recruitment, eligibility checking, treatment allocation and 
adverse events reporting, are seen in only one or two commercial systems” (2006, p. 386), 
but these systems are not named. 
However, the idea of automating eligibility checking of patients using a software tool is not 
new. Tu, et al. (1993) developed a language for expressing eligibility criteria in a machine-
readable way (e.g. HIV+ = true) OR (AIDS = true). For each criterion, a corresponding 
template had to be written for translation into a valid database query. This means that the 
criterion itself is not directly usable in finding matching patients. For every new criterion 
added, a corresponding query has to be defined. In the Eligibility Criteria Builder, the 
criterion becomes the query, and no additional mapping is needed. 
Ohno-Machado, Wang, Mar, & Boxwala (1999) developed a support system for clinical trial 
eligibility determination to help patients or their care providers to find ongoing studies of 
which the patient may be eligible (Ohno-Machado, et al., 1999). This situation is somehow 
different from the situation where a clinical study coordinator looks for potential participants 
by querying a database of patients, but the mechanisms used to match patients against 
eligibility criteria would be the same. In this study, the eligibility criteria were taken from 
unstructured protocol documents and manually translated into machine-interpretable 
statements using the Arden Syntax (see section 2.5). “The translation of the original free-text 
criterion descriptions (...) into a machine-interpretable representation was largely a manual 
process performed by informatics fellows and faculty in our laboratory” (Ohno-Machado, et 
al., 1999, p. 341). The intention with the Eligibility Criteria Builder is that this translation can 
be done by a study manager without the help from a programmer. 
Fink, et al. (2004) summarize a comprehensive amount of previous approaches to support 
both finding relevant trials for a patient, and finding potential patients for a clinical trial.  
However, the majority of these approaches are a matter of developing tools for entering the 
specific data needed to determine a patient’s eligibility status and holds the form “Has the 
patient had any previous cases of disease x?”. Thus, the development of such tools may 
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become a one-time activity valid only for a specific trial and does not take into consideration 
that the data (or at least data structure) needed for answering such a question may be 
available in an existing, available patient database. 
In OpenClinica, patient selection is a manual process as there is no feature of defining the 
inclusion/exclusion criteria as rules that will later be used in automatic selection of eligible 
patients. In the current version of OpenClinica (2.5) patients are marked enrolled to a study 
after they are determined by a clinician as eligible. 
2.5 Defining rules in healthcare - the Arden Syntax 
The Arden Syntax is a long-lived syntax specification for defining rules that applies in 
healthcare practice. It is used in defining Medical Logic Modules (MLMs), which is single 
rules that contains data and logic to help a clinician to make a decision at the point of care. It 
is intended to result in computer-readable rules that can be used to trigger alerts, reminders or 
suggestion about a patient at the time of encounter with a clinician. However, an MLM 
includes a part that references local, institution-specific healthcare data. Also, with Arden, a 
separate compiler must be written in order to integrate it with institutional data. As a 
consequence, in order to make a MLM written for one institution fit in to the context of 
another is a complex and time consuming task that requires highly skilled personnel. 
Attempts have been made to extend the Arden syntax to cope with the problem referred to as 
the “curly braces” problem (as local linkages are defined inside curly braces). The curly 
braces problem is still a present issue without any clear and immediate solution, and will 
most likely continue to be so until a globally accepted EMR standard is implemented and 
adopted across medical institutions. 
Another shortcoming of the Arden syntax is the lack of object-oriented features. The 
available data are limited to primitive (boolean, integers), and scalar (arrays, strings) only. 
Related pieces of data cannot be logically organized together as objects with attributes. 
Neither can data be accessed and references to as properties in a directed graph of objects 
with properties (objects as vertices and properties as edges). Attempts have, however, been 
made to introduce some object oriented features to the Arden syntax. (Jenders, Corman, & 
Dasgupta (2003) suggests the READ AS <object type> statement that instead of returning a 
list of primitives from the database, returns each matching row as an object where each 
column is mapped to their corresponding properties of the object type. This approach may 
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ease some of the shortcomings of the Arden syntax, but it does not solve the curly braces 
problem as it still requires references to a site-specific database. Thus, there is still a need for 
further decoupling of the database and how data is stored physically and the rules that access 
this data. 
Another attempt to improve the Arden syntax closer to the approach described in this thesis is 
the one by Choi, Bakken, Lussier, & MendonÇA (2006). Here, the authors argue that while 
the Arden syntax provides a mechanism to represent machine readable procedural 
knowledge, it is less suited for direct use by humans. The human readability aspect of MLMs 
has received little attention, but is nonetheless important of the “essential role of clinical 
experts in the development and maintenance of MLMs” (Choi, et al., 2006, p. 221). The 
Eligibility Criteria Builder is intended to produce rules that represent similar logic on a 
format that is intuitive and easier to understand and work with for a non-programmer. 
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2.6 Retrieving patients 
The OpenMRS Cohort builder (Figure 3) provides the possibility to search for a group of 
patients based of different criteria as personal data, demographics, drug orders and 
encounters. The searches can later be combined to create a cohort, represented as a subsection 
of patient Ids (a cohort is a population sample that share similar characteristics, i.e. age and/or 
citizenship). The cohorts are saved as a one-time cross-section of the matching patients and 
cannot be re-used to find matching patients that may be added to the database in the future.  
 
Figure 3: The OpenMRS Cohort builder 
The OpenMRS cohort builder does not support conditions spanning more than one attribute 
in the object graph. For example, searching for patients whose country of the preferred 
address is “Uganda” would pose a great challenge. You can require the citizenship to be 
Ugandan, but that is something different, as the patient’s current address may be somewhere 
else. The user interface of the OpenMRS cohort builder is also tightly coupled with the 
OpenMRS system itself, making it non-generic and thereby less suited for integration with 
other data models. 
2.7 Adverse Event Reporting 
As there are inclusion/exclusion criteria, there are also rules for adverse event reporting in a 
clinical trial. The caAERS system is a open source tool developed and maintained by the 
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Cancer Biomedical Informatics Grid  (caBIG) intended to support the definition and reporting 
of adverse events that can occur in a cancer trial (Whippen, Deering, & Ambinder, 2007).  
 
Figure 4: The caAERS rule editor 
The caAERS system (Figure 4) is web based, and provides some of the same features as the 
Eligibility Criteria Builder. It is however limited in functionality in some respects. For 
example, only subsets of root-level attributes are available for use in conditions, grouping of 
conditions is not allowed and the only allowed logical operator is AND. On the other hand, it 
provides richer functionality as it allows for custom actions based on rules. In the Eligibility 
Criteria Builder, the rules are used for either “Include” or “Exclude” actions.  They could, 
however, easily be used to trigger other types of actions, such as adverse event reporting. 
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3 RESEARCH METHODOLOGY 
In the same way as a clinician intervenes in humans in order to solve or prevent a problem 
(i.e. diagnosis) faced by their patients, this thesis proposes an intervention to solve a problem 
faced by clinicians in their everyday work. This kind of “intervention research” is not 
uncommon in social sciences and is dominated by two major methodological approaches, 
namely action research and design science (or design-based science). 
3.1 Action research 
The term action research was first coined by the German-American psychologist, Kurt Lewin 
in his paper “Action Research and Minority Problems” from 1946. Lewin described action 
research as “a comparative research on the conditions and effects of various forms of social 
action and research leading to social action” (Lewin (1946) as quoted in Susman & Evered 
(1978)). Action research originated as an approach to integrate research findings with 
practice in order to help the resolution of a social problem. Improvement and involvement are 
key features of action research. There is, first, the improvement of a practice of some kind; 
second, the improvement of the understanding of a practice by its practitioners; and third the 
improvement of the situation in which the practice takes place (Robson, 2002). This claim by 
Robson indicates that the improvement comes first, and then the knowledge is generated on 
the basis of how the improvement affected the surrounding environment. 
In action research, the researcher does not behave as a passive observer, but rather enter into 
the situation as an active participant working in close cooperation with the involved people to 
introduce a solution to the problem. The solution to the problem will be offered based on 
knowledge gained from initial observation of the problem area. The situation is then 
evaluated, to identify how the change affected the studied situation and the knowledge gained 
through evaluation is the outcome of action research. Both knowledge about the different 
aspects of the problem area and the effects of the introduced change are of high value. 
3.2 Design research 
In design research, the intervention is in the form of an new and innovative artefact that seeks 
to extend the boundaries of human and organizational capabilities (Hevner, March, Park, & 
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Ram, 2004). 
Design science has its origin in the Information Systems (IS) field (with its roots in artificial 
intelligence) and emerged as a counterpart to the predominant explanatory and predictive 
research traditions. Simon (1996) argued that design research is about finding out how things 
ought to be (Adikari, McDonald, & Collings, 2006). This may sound similar to the principles 
of action research which purpose is also to find a solution to a problem faced in a domain of 
interest. 
Design research does not only ask what can be done to improve the situation and how the 
improvement ends up affecting the surrounding environment. It is just as much about 
describing the actual design process. By asking “how can we best create the solution Y in 
order to solve the problem X in the best possible manner”, design research also emphasizes 
the knowledge gained during the process that led to the solution. 
3.3 Action research vs. Design research 
Both action research and design research view the researcher as an intervening part with a 
subjective opinion, not merely a neutral, objective observer as in traditional explanatory and 
predictive sciences. 
The distinction between design research and action research is not obvious. In fact, it can be 
argued that the two approaches share so many characteristics that they can be considered as 
similar to one another (Järvinen, 2005). Design research and action research differs, however, 
on some key points. Design research is usually researcher-initiated and grounded in theory. 
This point is elaborated by Wang & Hannafin (2005): “Before conducting design-based 
research, researchers (...) examine literature and available design cases, and identify gaps to 
ensure the value of the research (Edelson, 2002) and to identify existing problems and issues” 
(Wang & Hannafin, 2005). In action research, on the other hand, the research is usually 
initiated by practitioners in an immediate problematic situation. Theory, if it exists, is then 
used to propose a solution to the problem, and the proposed solution is in turn evaluated to 
build theory. 
Put simply, design research acts upon theory, while action research theorizes upon practice. 
For example, design science requires significant literature review and theory generation, uses 
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formative evaluation as a research method and utilizes many data collection and analysis 
methods widely used in quantitative or qualitative research (Orrill, Hannafin, & Glazer  
(2004) quoted in Wang & Hannafin (2005)). Action research generates theory grounded in 
action by applying theory in diagnosing situations and developing interventions, and by 
evaluating interventions to test the underlying theory (Andriessen, 2006, p. 5). 
In both cases, the purpose is to contribute both to practice and theory through iterations of 
acting and evaluation (Andriessen, 2006; Järvinen, 2005; Rapoport, 1970). 
3.4 Choosing a research methodology 
Because of the close resemblance of action research and design research as shown by 
Järvinen (2005), it is not very meaningful to claim that this thesis belongs to one or another of 
these approaches. Rather than classifying the methodological approach of this thesis as either 
action research or design science, I would argue that it uses elements from both of them. It 
may belong to action research in the way that its motivation arose from a practical problem 
faced by practitioners, rather than from a thorough literature review leading to a discovery of 
a gap in previous research. It may belong to design research in the way that the development 
of the solution (prototype) is not merely a means to an end, but just as much a way of 
enabling the researcher to learn about the real world, how the artefact (prototype) affects it, 
and how users appropriate it (March & Smith, 1995). 
3.5 Development methodology 
Sommerville defines a prototype as “an initial version of a software system that is used to 
demonstrate concepts, try out design options and, generally, to find out more about the 
problem and its possible solutions” (Sommerville, 2007, p. 409). There are two common 
prototyping approaches: evolutionary (or incremental) prototyping and throw-away 
prototyping (Avison & Fitzgerald, 2003, pp. 89-90). The latter is usually a quick non-
functional (or limited in terms of functionality), mock-up or sketch of the intended system, 
used to visualize and ease the understanding of the system or specific features of it that may 
be different to imagine otherwise. Throw-away prototyping is quick (the user can typically 
see a sketch of system and test some functionality in a couple of days), but has, however 
according to Avison & Fitzgerald (2003), a few limitations. Most notably, it does not scale 
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well and is unsuitable or difficult to integrate with operational systems. Another shortcoming 
is the problem of spending time developing something that never will be used later. When the 
customer (or end-user) decides that the prototype is “good enough”, the prototype is thrown 
away, and the final system is being implemented. Herein lays the key difference between 
evolutionary prototyping and throw-away prototyping; in evolutionary prototyping, the 
development is considered “done” when customer satisfaction is met, while in throw-away 
prototyping that is when the real development starts. Nothing is thrown away using the 
evolutionary approach, except features that may have been disclosed as unnecessary through 
the user-evaluation. Evolutionary prototyping is about constantly evolving the prototype so 
that it steadily moves towards a finished product.  
The development of the Eligibility Criteria Builder followed an evolutionary prototyping 
approach, in which the development took place in three iterations (or increments), with each 
iteration delivering an improved version of the prototype. The Eligibility Criteria Builder 
should still be regarded as a prototype as it used to demonstrate a concept and find out more 
about a problem and its possible solutions, which fits well with Sommerville’s definition of a 
prototype as initially quoted in this section. 
3.6 Usability evaluation 
What is usability? The most common definition of usability is the one given in the ISO 
standard 9241: 
“The effectiveness, efficiency and satisfaction with which specified users achieve specific 
goals in particular environments” 
The different components of this definition, effectiveness, efficacy and satisfaction are 
further explained by Dix, Finlay, & Abowd (2004): 
o Effectiveness refers to the accuracy and completeness with which specified users can 
achieve specified goals in particular environments 
o Efficiency  refers to the resources expended in relation to the accuracy and 
completeness of goals achieved 
o While satisfaction is the comfort and acceptability of the work system to its users and 
other people affected by its use 
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According to Dix et al., usability evaluation has three main goals: (1) to assess the extent and 
accessibility of the system’s functionality, (2) to assess users’ experience of the interaction, 
and (3) to identify any specific problems with the system (Dix, et al., 2004, p. 319). The first 
goal is about finding out to which extent the system solved the task it was intended to solve 
from a users perspective. The second goal is concerned about how the users experience the 
interaction with the system. A clear definition of usability and the goals of usability 
evaluation enable the development of different techniques to assess the extent to which the 
software meets the user requirements. 
Several evaluation techniques exists and choosing between them is a matter of available 
resources, at what stage in the development lifecycle the evaluation takes place, nature of 
study (laboratory/field), level of objectivity needed, and type of measure required to name a 
few (Dix, et al., 2004). It is impossible to do all types of evaluations and there exists no 
evaluation technique that covers all possible aspects of the studied subject. Therefore, 
choosing an evaluation technique is always a trade-off and a matter of selecting the most 
appropriate technique within the limitations of the study. 
At the end of the first development iterations, usability evaluations were conducted by taking 
notes while going through the features of the new version. 
The characteristics of the Eligibility Criteria Builder are: 
(a) It is a web-application 
(b) It is intended to support a complex task in order to solve a real-life problem faced by  
clinical researchers 
(c) It is a prototype, in an early development stage, meant to test a concept/idea 
Because of (a) it can easily be administered to people around the world. This affects 
availability of test-users that potentially can be recruited from all over the “connected” world. 
On the other hand, because the target users are clinical researchers (b), it limits the group of 
potential participants to those with this background (ideally, they should also have experience 
from conducting clinical research in the developing world), i.e. it is not a matter of asking 
fellow students (which are easily accessible) for their participation. 
Because of (c) it is not possible to observe the system in a completely natural setting. The 
evaluation tasks are artificial, so the participants have to imagine themselves building the 
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given eligibility criteria tasks for an imaginary study. This excludes field study as a feasible 
technique in evaluating the prototype. 
The time constraint posed by a master’s thesis and the possible remoteness of available 
participants meant that the best available option for assessing the usability of the prototype 
was using a questionnaire. A combination of the Systems Usability Scale (SUS) and open 
questions were used. See section 5.2 for a description of SUS. 
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4 SYSTEM DESIGN AND IMPLEMENTATION 
This chapter includes a description of the development process in the design research and the 
incremental evolutionary prototyping approach that was adopted. 
As opposed to throwaway prototyping, evolutionary prototyping involves continuous 
refinement of the system. The prototype was developed in three iterations, each resulting in a 
set of improvements from the previous one. 
4.1 Initial requirements analysis 
The initial requirements analysis was based on conversations with different clinical 
researchers with experience in the planning of clinical trials. The conversations took place 
during the OMEVAC kick-off meeting in Kampala, Uganda. The requirements was then 
refined and described in more technical terms in the next section. 
4.1.1 General requirements 
A system enabling clinical researchers to formulate a list of computer-interpretable eligibility 
criteria would require interaction with an existing data model and available resources 
(demographics data, observational data, case report forms, etc.). The prototype should not be 
bound to a specific data model, but rather developed as a generic tool that could be adapted to 
any data model with as little effort as possible. During development and evaluation, there was 
however a need for an example data model to which the system was tested against. Therefore, 
the prototype was developed using the OpenMRS API4 as an example of what the data model 
might look like. The OpenMRS data model is based on the data model of the Regenstrief 
Medical Record system which has been in production use more than 30 years and contains 
patient demographics, drug orders, observations, patient encounter forms, and a concept 
dictionary (Mamlin, et al., 2006). It is written in Java and made freely available by download 
from the OpenMRS website as a Java Archive (jar) file ready to be integrated in other Java 
                                               
4
 API stands for Application Programming Interface, and is an abstraction of the underlying 
relational database model. The OpenMRS data model therefore refers to the OpenMRS API 
throughout this thesis 
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based systems. 
4.1.2 Initial functional requirements 
A rule editor which allows the user to do the following: 
o Define variables 
o Define variables based on aggregated data 
o Define variables based on expressions or other variables 
o Use variables in logical expressions 
o Declare variables based on available resources (patient journals and case report 
forms) 
o Continuous assisting the user in the process of formulation by: 
 Instant hinting of available options or possible next steps (i.e. selecting a 
patient blood type property).  
 Storage and retrieval of expressions or rule sets for later use. 
4.1.3 Non-functional requirements 
o A graphical user interface enabling easy formulation of eligibility criteria 
o Expressions should be valid in the given context (with the same resources available) 
4.1.4 Required resources 
The system will need access to at least one of the following type of resources: 
o Electronic Patient Journals 
o Electronic Case Report Forms 
4.1.5 Expressiveness 
The expressions formulated in the system should be ranging in complexity from simple to 
complex where the most simple could be requiring “patients to be above 18 years old” to 
more complex, expressions spanning across collections based on selection criteria on the 
collection items (i.e. patient has an observation where the question is “are you pregnant?” and 
the answer is “yes”). Because a patient can have several observations, the collection selection 
criterion is “question is “are you pregnant””. In addition, the system should enable the basic 
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logical operators AND and OR, and parentheses (or groups) that can be negated. 
4.2  System design 
The prototype was developed iteratively following an incremental, evolutionary prototyping 
approach. The prototype was continuously improved in accordance to feedback given by 
potential users including Jørn Klungsøyr at Centre for International Health at the University 
of Bergen. 
The idea of the eligibility criteria builder emerged from a plan of developing a more general 
study protocol management tool. A formalization of the eligibility criteria section in the 
protocol was identified as a significant improvement to the current practice. At the same time, 
it is a great challenge because it deals with formalization of natural language and represents 
written statements in natural language in a computer-understandable format without 
compromising the semantics of the written statements on the way. In addition, a system like 
this should be usable for study managers who may not be experienced programmers. For a 
skilled programmer, it is undoubtedly easier to formulate criteria in a programming language 
syntax using a text-editor or the supporting features provided by an IDE (Integrated 
Development Environment). The idea of developing the prototype as an IDE plug-in was 
explored in the beginning, but later rejected because of the great complexity of this approach 
and because of the programming knowledge required from the user. 
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4.2.1 Original design - sketch 
 
Figure 5: Early conceptualization of the prototype on a piece of paper. Each rectangle 
represents a selection field. 
As shown in Figure 5, the sketch illustrates what happens when the user selects the age 
property of the patient class. Because the age is an integer value, the list of possible operators 
reflects those valid for numeric values. The last empty rectangle would be where the user 
typed the value(s) for the condition. 
4.2.2 The programming language approach 
The idea of developing the prototype as an integrated development environment (IDE) was 
considered as a feasible alternative in the beginning. A mock-up was therefore developed 
using the Netbeans Platform5, which is a framework for developing Java based desktop 
applications built on top of the Netbeans IDE application. Basically, it works by selecting the 
essential features needed in one’s custom application, and extending these functions as 
desired. This means that the mock-up could quite easily be founded on the IDE features (i.e. 
syntax highlighting) of the Netbeans platform. The language selected for the Eligibility 
criteria syntax was a simplification of the Groovy6 language. A Groovy language definition 
                                               
5
 http://platform.netbeans.org 
6
 http://groovy.codehaus.org/ 
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file for the Netbeans platform was described in a blog entry by Geertjan Wielenga7, and based 
on that, a mock-up was implemented on the basis of the initial requirements. 
 
Figure 6: Mock-up using the Netbeans platform 
As seen in Figure 6, the user can state its eligibility criteria in an integrated development 
environment (IDE). The project explorer to the left shows the different parts of the protocol, 
with the rules for eligibility organized in its own section/folder as separate files with the CTR 
file type (clinical trial rule). 
Editing a file with the CTR extension will make the editor view in the middle apply the 
appropriate syntax colouring scheme and perform syntax validation according to the defined 
language definition file. Each criterion is stated on a new line in as conditional expressions 
that evaluates to true or false. The dropdown list below the cursor shows the valid properties 
available for user selection. 
The right pane in Figure 6 lists the criteria in the current edited criteria file for easy 
navigation between them. 
                                               
7
 http://blogs.sun.com/geertjan/entry/how_to_write_a_groovy 
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The programming language approach was however found to have several drawbacks: 
• Heavyweight application framework: This meant longer compile-time and less rapid 
development of new features. 
• Complex application framework: The Netbeans code base is comprehensive and much 
more time was spent on figuring out how the different parts worked (and making them 
work together) rather than focusing on implementing the actual required features. 
• End user availability and client requirements: The resulting application was about 10 
MB of size, and had to be downloaded and installed on the client computer. 
• Higher technical knowledge required by the end user. This approach would demand 
the end user to hold at least some programming knowledge.   
The programming language approach might have been less restricted and provide a great deal 
of freedom for the user (i.e. placing the cursor anywhere in the file and start typing), but 
because of the reasons given above, a decision was made to change the approach from a 
traditional desktop application development, towards developing a web-application with a 
less complex dropdown-based user interface.  
4.2.3 Web application using Grails 
Grails is a web application framework that facilitates rapid web development, and was 
selected because of its reputed ease of implementation and suitability for integrating with 
existing Java libraries (like the OpenMRS API). 
“(...) Grails, which is an open source framework that aims to simplify Web development. 
Grails is written in Groovy, a dynamic, object-oriented language that runs on the JVM (Java 
Virtual Machine). Because Groovy interoperates seamlessly with Java, Grails can leverage 
several mature Java frameworks.” (Richardson, 2008) 
  Using Grails and developing the prototype as a web-application facilitated rapid 
development of new features and put less system requirements on the user as it can then be 
opened and run in a browser from anywhere.  
First prototype: System architecture and user interaction 
In the first prototype using the web application approach, the architecture infrastructure was 
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established together with a preliminary version of the user interface. 
On an architectural level, the prototype works by the user interface (UI) in the front-end 
listening for user actions (i.e. a mouse click on a button) and giving appropriate responses to 
those actions. If the action requires information from the server, the front-end sends a request 
to the server, asking for the needed information. The server responds to the client-initiated 
request and returns the appropriate data which is examined by the front-end and presented to 
the user through the user interface. Figure 7 shows a model of the system architecture. 
 
Figure 7: Overall system architecture 
Apart from the system architecture, an early version of the user interface was implemented in 
this iteration. The ability to provide the user with hints on what properties and what operators 
were available for selection were considered as of high priority in the requirements analysis. 
As the approach moved away from the notion of the prototype being an IDE facilitating 
simplified programming, so some of the requirements initially stated were not as relevant 
anymore, resulting in the requirements being re-prioritized. Those assisting the user in the 
formulation of the criteria were put in higher priority than those dealing with the notion of 
variables. This is reflected in the user interface, as shown in Figure 8 
The OpenMRS data model was used as an example for testing with the properties of its 
Patient class as the starting point for each criterion. However, as the aim was to develop the 
prototype as generic as possible, direct dependencies between the front-end and the 
OpenMRS library were avoided. 
29 
 
 
Figure 8: The first web-application prototype 
Figure 8 shows three properties of the OpenMRS Patient class used in an expression. Each 
line has a dropdown box for choosing the Patient property, a dropdown box for selecting a 
valid comparison operator, and an input box for entering the value to compare with. The list 
of valid comparison operators depends on what property is selected. For instance, the 
property “Age” refers to an integer value, and therefore the user can choose between all valid 
integer operations. “CauseOfDeath” is a concept, and the user is therefore given the 
opportunity to search for valid concepts stored in the database. The user can type in at least 
two characters and the system will list all the concepts that start with these two characters. 
After the end of each line, the user is given the option to add a new condition (plus button) by 
selecting the logical operator (AND/OR) to use in between, or deleting the condition by 
clicking the button with a minus sign on it. 
The corresponding logical expression is shown in the upper box in Figure 8. This reflects the 
expression formulated in the UI as source code in the Groovy language. 
Second prototype 
In this iteration, the user interface was improved in terms of stability, visual impression and 
functionality. Improvements include the ability to perform basic operations like storage, 
retrieval and deletion of expressions (as specified in the requirements analysis), naming 
expressions and viewing them in XML format. The user can select any of these operations 
from buttons on the introduced toolbar, as seen in Figure 9. End-user documentation was also 
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included in this version. 
 
Figure 9: The user interface from the second iteration 
The buttons at the end of each line were improved with icons, and options for adding new 
groups were placed in a separate button. Also, the code view was moved below the Criteria 
expression, to put the workbench in focus (see Figure 10 for the names of the different parts 
of the UI). 
For this iteration, tasks covering the range of functionality offered by the prototype were 
designed in order to test the prototype. The test tasks for this iteration were the same as the 
one used in evaluation (see section 5.3.5).  
The tests were done by Jørn Klungsøyr at Centre for International Health. He revealed 
several usability issues: 
• It was impossible to remove a group. If the user made a mistake by clicking the add 
group button, there was no way to remove this expression group again.  
• It was not possible to add a group immediately after another group. This had to be 
done by first adding a group, then adding two other groups after the expression inside 
this group. 
• Most notably, if one started by adding a group, there was no way of adding a new 
expression after it. 
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Final prototype 
Based on the feedback from the second iteration tests, the final prototype was developed. 
It was suggested to add the "remove, add and group" buttons before or after a group-
parenthesis. This led to the development of the Expression Toolbar (see Figure 10), 
responsible for adding and removing expressions and expression groups before or after both 
single expressions and expression groups. 
This resulted in these three buttons appearing rather more frequent than before, and to tone 
down their visual impression and dominance in the GUI, these buttons were reduced to icons 
only (with a describing tooltip text) and made transparent when inactive (opaque on mouse 
over). A more thorough description of the user interface in the final prototype follows. 
The final user interface 
The user interface in the final prototype now consists of four different parts. A toolbar, an 
information pane, the expression workbench and a code view. The toolbar offers basic 
operations for the creation, saving, re-opening and deletion of expressions. For demonstration 
purposes, an option to download and view an XML version of the current expression is also 
available. Lastly, the toolbar has a button that opens the user-documentation in a new 
window. This makes the documentation available to the user at any time. 
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Figure 10: The final prototype and its different parts 
The information panel contains information about the current data model. During the tests, 
this panel also included task-number and criteria type selection boxes and a field for the 
textual description of the criteria expression. See section 5.3.5 for more information about the 
user tasks used in evaluation. 
Information pane 
Workbench 
Code view pane 
Toolbar 
Expression Toolbar 
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The workbench pane is where the user formulates his/her criteria by building the expression 
piece by piece. When creating a new expression, three separate dropdown-boxes are shown. 
The first is where the user selects the property to use in the condition. When the user selects a 
property from the first dropdown, the next one will be updated to contain the valid 
comparison operators for the data type of the selected property (remember that a property is 
actually a get-method with a return-type). For example, if the property type is an integer, the 
next selection box will display a selection of comparison operators valid for integers (i.e. less 
than, greater than... etc.). If, on the other hand, the selected property returns a complex data 
type, like a patient or person, the comparison-operator selection box will also include the 
properties of the return type (i.e. birthdate for a person). If the user selects one of these 
properties, a new dropdown will be added before the comparison operator selection box, 
containing the chosen property, and the comparison operator will be re-populated with 
comparison operators valid for the data type of the selected property (in the case of birth date: 
“is before”, “is after”, etc.). 
The last field is always the value in the expression. The value can be either primitive, 
(numbers, strings) or complex (referring to actual instances, i.e. the user with id=2). 
The registered lookups, as described in section 4.3.2 - Lookups, determines what values 
should be suggested as alternatives for the different data types. 
When the user is finished with the first condition, he/she can go on by adding another 
condition by clicking the “Add” button to add a single condition or the “Group” button to add 
a grouped condition. Before adding a new condition, the user must decide whether to add the 
condition before or after the current. When the condition is added, the user also needs to 
select the logical operator (either AND or OR) between them. When adding a grouped 
condition, the user can also optionally negate the newly added group (i.e. put a NOT before 
it). 
The code view is for demonstration purposes only, showing the current expression as a 
Groovy expression. 
Creating a new expression from scratch 
To create a new expression, the user clicks the “New” button on the toolbar. 
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Along with a field for entering the expression name, three blank fields will appear in the 
workbench (see Figure 10). The first field gives a list of all the properties associated with the 
root-class as defined in the backend.  
The user will need to give the expression a name by filling in the "Expression name field" 
This will typically be a textual description of the criterion the user would like to create. In 
order to force the user to provide a name for the expression, a dialog box will appear if he/she 
tries to save the expression without yet giving it a name. 
Open an existing expression for editing 
To open an already existing expression, the user clicks the “Open” button on the toolbar. This 
will display a list of all the existing expressions in the database. The user then selects the 
expression he/she wants to open from the dropdown list. The expression will now appear on 
the workbench, ready to be edited. 
Deleting an expression 
To delete an expression, the user clicks the “Delete” button on the toolbar and will then be 
asked to confirm that the expression should be permanently removed. 
4.3 Implementation 
4.3.1 Technologies used 
Several different technologies were used in the development of the prototype. They are listed 
and described below. 
Grails, Groovy, JavaScript 
The back-end was implemented using Grails, an open-source, Java-based web application 
framework. Grails enabled easy integration with the OpenMRS API, and facilitated rapid 
development of the prototype back-end. Grails is itself built on top of other technologies such 
as the Groovy Scripting language for Java. The flexibility offered by Groovy made it possible 
to add functionality to built-in Java-classes and imported library classes. 
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JavaScript was used on the front-end to request, receive and manage the information from the 
back-end. Requests were sent from the UI whenever the user action required it. 
The Java Reflection API 
A crucial feature of the Java programming language utilized in this project was the ability to 
read metadata of the different language constructs (classes, data types, methods, etc.) through 
the Java Reflection API which allows the program to introspect on itself at runtime. For 
example, by using the introspection features, it is possible to write code that can tell the user 
what methods and class it is running inside. A description of how reflection is utilized in this 
project is presented later in this chapter. 
Dynamic features of Groovy 
Groovy provides support for dynamically adding behaviour and properties to classes at 
runtime. To exemplify this, consider extending the built-in Java-class java.util.Date with a 
“getYearsSince()” method that returns the number of years since the date the object 
represents. In traditional Java, this can only be achieved by subclassing the java.util.Date 
class. In Groovy, however, this method can be added to the Date class at runtime with the 
following code: 
java.util.Date.metaClass.getYearsSince = {  
    return new Date().getYear() - delegate.getYear()  
}  
  
date = new Date(80, 1, 2)  
  
println date.getYearsSince() 
 
>> 28 
This feature was especially helpful as it enabled the possibility to add custom functionality to 
instances of library classes with little effort. To illustrate the advantage of this feature, 
consider the Patient class in the OpenMRS API. The Patient class has its own compile-time 
methods, like getAge, getTribe, etc. The data model also has an Observation-class (named 
Obs), with a reference to the patient, made available through the method with signature 
public Patient getPatient(). There is however, no reference from the Patient class to 
observations linked with patients. The problem is: how do we implement a method, available 
on all patient-objects that give us the list of observations registered for them? The intuitive 
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approach to this could be by subclassing the Patient class with, say an ExtendedPatient class 
and implement a new method returning a list of observations. Something like: 
class ExtendedPatient extends Patient { 
public Collection<Obs> getObservations() { 
 // Fetch and return observations for this patient 
} 
} 
Now, this would ensure that all “extended patients” (instances of the ExtendedPatient class) 
in the system has a method that returns a list of observations for the patient. But consider also 
the observations in the list that this method returns. These are instances of the Obs class and 
still got the function getPatient which still returns a Patient object, not an ExtendedPatient. 
Thus, the achievement of writing the ExtendedPatient class is really limited unless one 
subclasses and overwrites methods throughout the entire data model. With Groovy, the 
getObservation-method can be added runtime with the following piece of code: 
Patient.metaClass.getObservations = {  
  // Fetch and return observations for this patient  
} 
Groovy will now ensure that all instances of the Patient class or subclasses of it have a 
getObservation method. 
Groovy does not, however support statically typed return-type of dynamically added 
methods, something that disables introspection features on them. To cope with this, the 
Groovy class TypeExtensions was written to enable borrowing of methods from a statically 
typed Java-class while keeping track of return values of the borrowed methods (see  
Appendix F for the whole class). 
class TypeExtensions {  
    private static HashMap<Class, Class> extenders = new HashMap<Class, Class>();  
  
    /**  
     * Adding methods of extender class to the extendee class  
     * All instances of the extendee class will have methods of the extender class  
     */  
    public static extend(Class extendee, Class extender) {  
        extenders.put(extendee, extender)  
        for (Method m in extender.getDeclaredMethods()) {  
            def method = m.name  
            extendee.metaClass."$method" << {->  
                extender."$method"(delegate)  
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            }  
        }  
    }  
    /**  
     * Returns a list of methods for extended class  
     */  
    public static List<Method> getAllMethods(Type clazz) {  
        if (!clazz) return null  
        if (extenders.containsKey(clazz))  
            return Arrays.asList(clazz.getMethods())  
                    .plus(Arrays.asList(extenders.get(clazz).getMethods()))  
        else  
            return Arrays.asList(clazz.getMethods())  
    } 
(...) 
} 
The extend method in the above Groovy class takes two classes as parameters. The first class 
is the one to be extended (the extendee) with the methods belonging to the class in the second 
parameter (the extender). When called, the extend-method first adds the extender class to a 
hash map (using the extendee as key) for later use. Then, the methods of the extender class 
are looped through, adding each method to the extendee class using its metaClass. The new 
method of the extendee is a code block calling the original method of the extender with itself 
as parameter. That’s why all methods of extension classes must have the first parameter being 
of the class it intends to extend. For example, the method returning observations for a patient 
described earlier would be required to take a Patient object as parameter: 
public static Collection<Obs> getObservations(Patient delegate) {  
    // Fetch and return observations for the delegate patient  
}    
JSON as exchange format 
JavaScript Object Notation (Crockford, 2006) is a lightweight data exchange format that is 
easily parsed by JavaScript. It was therefore very suitable as exchange format from the back-
end to the front-end. The front-end sends request by regular get and post requests, while the 
back-end returns a JSON structured response to the request. Grails comes with a converter 
that easily transforms a Groovy object to a JSON object: 
def employeesAsJSON = Employee.list() as JSON  
println employeesAsJSON 
 
>> [{"id":1,"class":"Employee","address":2,"age":28,"birthDate":new 
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Date(332231400000),"department":1,"firstName":"Jim","jobTitle":"Student","lastName"
:"Ojam"},]  
Class introspection and generics 
Type introspection capability is required from the underlying data model in order to enable 
reading of return type values for the different classes and properties in it. 
Java is a reflective programming language, which means it offers the possibility to introspect 
on its own language constructs and obtain meta-information about classes, methods, return 
values and parameters. For instance, it is possible to determine what kind of class an object is 
an instance of: 
static void printClassName(Object o) {  
System.out.println("The object is an instance of: "+o.getClass())  
}  
Invoking this method with a date object as parameter will produce: 
printClassFor(new Date()) 
>> The object is an instance of: class java.util.Date 
It is also possible to list all the methods available for an object by reading declared methods 
of the class the object is an instance of: 
printMethodsFor(new Date()) 
>> public int java.util.Date.hashCode() 
public int java.util.Date.compareTo(java.lang.Object) 
public int java.util.Date.compareTo(java.util.Date) 
public java.lang.Object java.util.Date.clone() 
public boolean java.util.Date.equals(java.lang.Object) 
 
public java.lang.String java.util.Date.toString() 
(...) 
This type of metadata is read from the data model by the back-end, and returned for use by 
the front-end, for example when determining what comparison operators to show when the 
user selects the age property of the patient (which actually refers to the getAge() method of 
the Patient class, as explained in the following section). 
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JavaBean naming pattern 
The JavaBeans component architecture specifies a naming convention for classes and field 
accessors. A common convention is to expose private fields of a class through getters and 
setters, allowing the outside world to retrieve and manipulate the field. If we consider the 
field private Date birthdate in the class Person, the corresponding getters and setters for 
this field would be: 
    public String getBirthdate() {  
        return this.birthDate;  
    }  
    public void setBirthdate(String bd) {  
        this.birthDate = bd;  
    } 
According to the JavaBeans specification, birthdate would be said to be a property of the 
Person class. 
In Groovy, properties following the JavaBean naming convention are accessible using dot 
notation. For example, given an instance of the Person-class, the person’s birthdate would be 
written as: 
person.birthdate  
This would implicitly invoke the getBirthdate -method (i.e. not by accessing the private 
“birthdate” field directly, which would violate the access restriction on the declared birthdate 
field). 
The birthdate field is of the java.util.Date type which itself has its own getters and setters, 
like getYear and setYear. Correspondingly, the year of the person’s birth date can be 
expressed as: 
person.getBirthdate().getYear() 
This is, no matter how readable for an experienced programmer, a less natural way of 
referring to a person’s year of birth. In Groovy, the same thing would be written: 
person.birthdate.year 
In a more complex and comprehensive data model, like the OpenMRS, one can express fairly 
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readable references to properties along an object path. For instance, the birthdate of the 
person who created a form used in an encounter associated with an observation would be 
represented as: 
observation.encounter.form.creator.birthdate 
So, in short, the JavaBeans naming convention provides a more natural way of representing 
properties along paths in an object hierarchy. 
This notation is used consistently in the front-end to provide a more readable representation 
of a condition, for example: 
observation.encounter.form.creator.age is less than 18 
Java generics 
The introduction of reflection and generics in Java 1.5 opened for the possibility to “know” 
about the data type of items contained in collections. Prior to Java 1.5, element accessors of 
collection classes would only return instances of the built-in Object class. This class is the 
superclass of all objects in Java, so any object returned from a list would be an instance of the 
this. Thus, no further specification of the type objects contained in a collection was available 
prior to introduction of the reflection API. 
For example, the generics features allows the siblings field in the Person class underneath to 
be declared as a list of other person-objects in the following way: 
private List<Person> siblings; 
The corresponding get-method would look something like: 
public List<Person> getSiblings() { 
 return siblings 
} 
Introspecting the getSiblings method would now determine that it returns a list of person-
objects: 
Method method = Person.class.getMethod("getSiblings", null);  
System.out.println(method.getGenericReturnType()); 
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>> java.util.List<Person> 
The information about the type of items in collections is used by the front-end to let the user 
set conditions on the items, in order to single out a desired item to use in the expression. For 
example using the where pseudo-operator: 
patient.addresses.where(preferred is true).country equals “Namibia” 
Here, the front-end will recognize the property addresses as a collection, and ask the back-
end for what type of items it contains. The back-end will use introspection to read the 
enclosed type of this collection and answer that it contains objects of the Address class. The 
front-end will then go on by letting the user set conditions on the properties of the Address 
class (in this case, the country attribute refers to the address in the list where the preferred 
property is set to true). 
Other Javascript libraries used 
Several JavaScript libraries were used; The Prototype JavaScript framework was used to 
utilize object-oriented features in Javascript (which by default are rather limited), ease the 
creation of extended HTML components, and simplify DOM manipulation and Ajax 
requests. The script.aculo.us user interface library was used for visual features, while JQuery 
was used for the date selector widget and embedded dialog windows. Because different 
browsers have different XML APIs, the Sarissa library was used to ensure cross-browser 
compatible XML serialization. 
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4.3.2 Prototype implementation 
Technical architecture  
 
Figure 11: Architecture of the prototype 
The prototype is made up of two separate, independent parts. On the server-side lays a Grails 
web application, which is responsible for interacting with the data-model by reading metadata 
about its classes and properties, and retrieving relevant data from the database. The 
communication between the two parts is done through Ajax requests. The front-end requests 
data from the back-end whenever needed by posting HTTP requests and receiving the 
appropriate data as a JSON-encoded response. 
The back-end application can be deployed in several Java Servlet containers, like Tomcat, 
Geronimo, GlassFish, JBoss etc8. For the evaluation session, the prototype was deployed in 
Jetty9. 
The client side application is tested throughout the development stage using Firefox 3.0. It is 
briefly tested in Opera and Google Chrome without any clear incompatibility issues. 
However, the time constraint given this thesis did not justify thorough cross-browser 
compatibility checks. 
                                               
8
 For a whole list of supported containers, please refer to 
http://docs.codehaus.org/display/GRAILS/Deployment 
9
 http://www.mortbay.org/jetty/ 
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Front-end 
Expression structure 
The front-end lets the user manipulate the different structural parts of an expression. To 
formally describe the syntax of a programming language, the Extended Bakus-Naur Form 
(EBNF) is widely adopted and used. The structure of an expression, as can be formulated and 
manipulated using the prototype can be described using EBNF grammar as: 
expression  = condition [{(AND | OR) condition}]. 
 
condition  = single_condition | expression_group. 
 
expression_group  = [ "not " ] "(" expression ")". 
 
single_condition  = property {["." property]} comparison_operator value. 
 
property  = propertyname ["["condition"]"]. 
This grammar can be visualized using the EBNF Visualizer application10. See Appendix I for 
a visual representation of the expression syntax. 
The register 
The register is a data structure used by the front-end to keep track of data model-specific 
features. The front-end totally de-coupled from the back-end and knows nothing about the 
underlying data structure or specific programming language constructs, this information is 
kept in the register. The prototype only knows that it must consult the register to obtain 
this information. The register supports three distinct language constructs: data types, 
comparison operators and value lookups. 
Data types 
Data types can easily be registered using the Register.Datatype.add(options) function, 
taking a list of options (JSON-style) as parameter. 
A data type must always have an id. This should be a simplification of an actual data type in 
the programming language. For instance “java.lang.String” would typically just be given 
                                               
10
 http://dotnet.jku.at/applications/Visualizer/ 
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“string” as id. Data types can also have a list of aliases that would be which data types that 
should be generalized to it. Because the aliases are used to determine what comparison 
operators that are valid for each of them, the data types can be a quite broad simplification of 
those supported by the programming language. For example, instead of registering all 
numeric data types found in Java as separate, independent data types, they could be 
generalized into a “numeric” data type in the register: 
Register.Datatype.add({  
    id: 'numeric',  
    aliases: [  
        'java.lang.Integer',  
        'java.lang.Double',  
        'java.lang.Long',  
        'java.lang.Float',  
        'byte',  
        'short',  
        'int',  
        'long',  
        'float',  
        'double'  
    ]  
}) 
The prototype will then treat all of the data types listed in aliases to be numeric, suggesting 
the same list of comparison operators to all. 
Data model specific data types (i.e. classes) can also be registered using the same function. 
For instance, enabling support for instances of a customized Person class can be achieved by 
adding it to the register: 
Register.Datatype.add({  
    id: 'my.package.Person'  
}) 
 
Comparison operators 
Different data types have different comparison operators. These operators can be added to the 
register and will appear as options when the user encounters an associated data type. The data 
type association is specified when registering the comparison operator in the register. 
Consider the comparison operator “equals” (the “==” operator in groovy). It will be valid for 
a range of data types, including strings, numeric types, dates, etc. The equals operator can 
therefore be registered with the id of the associated operators: 
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Register.ComparisonOperator.add({  
    id: 'equals',  
    symbol: '==',  
    display_name: 'is',  
    datatypes: ['numeric', 'string', 'boolean', 'date']  
}) 
Note that a comparison operator can also have a display name. This is what will be visible to 
the user in the GUI. 
Logical operators 
The only logical operators currently included are AND and OR. Support for other operators 
(i.e. exclusive or, XOR) can be enabled by adding them to the register: 
Register.LogicalOperator.add({  
    id: 'xor',  
    symbol: '^',  
    display_name: 'xor'  
}) 
Lookups 
The last, but not least important feature of the register is lookups. Lookups can be added to 
suggest different selection choices for the user. For instance, the list of available properties 
for a class is retrieved consulting the lookup register. A lookup can be either a hard-coded list 
of values, or an Ajax request to retrieve objects from the backend. For example, the lookup 
for boolean data types would be: 
Register.Lookup.add({  
    id: 'boolean',  
    datatypes: ['boolean'],  
    getItems: function() {  
        return [true, false]  
    }  
}) 
A lookup that would retrieve a list of users from the backend would be: 
Register.Lookup.add({  
    type: 'request',  
    id: 'persons',  
    datatypes: ['my.package.Person'],  
  
    request: function(args) {  
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        var url = 'backend/get_persons?' +  
                  'match='+encodeURI(args.match)+  
                  '&datatype='+encodeURI(args.datatype)  
  
        new Ajax.Request(url, {  
            evalJSON: true,  
            onComplete: function(response) {  
                var json = response.responseJSON;  
                this.respond(json)  
            }.bind(this)  
        })  
    }  
})  
Lookups registered with the option “type: request” will need to define a responder callback 
function, which is invoked when the Ajax request is done loading the response. 
It is only in the lookup segment of the register that the prototype keeps the information about 
the back-end. In essence, the front-end and the back-end are totally de-coupled - neither 
knowing anything about the other. The front-end only knows it must get the information from 
somewhere, and therefore it consults the lookup register to find out from where. It is only the 
implementation of a lookup that keeps a reference to the back-end. The back-end, on the 
other side knows that it serves a front-end, and therefore it must conform to the standards 
required by it. In the prototype, the front-end and the back-end are on the same server, 
therefore the URLs defined in the lookups are relative. 
The classreader lookup 
The only lookup required by the front-end is the classreader lookup. The implementation of 
this must return a list of PropertyNodes corresponding to the given arguments its request-
function is called with. It does so by consulting the back-end. The current implementation of 
this lookup is reproduced in Appendix E.  
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Expression nodes 
 
Figure 12: The different language constructs represented as TokenNodes 
The different parts of an expression as described above, is represented as subclasses of the 
TokenNode JavaScript class in the file ExpressionNodes.js. 
The TokenNode super class is implemented as a linked list, allowing each node to have other 
nodes linked either before or after. For example, a PropertyNode can be followed by another 
property node, and a condition can be followed by a logical operator, which in turn is 
followed by another condition. A description of the subclasses of the TokenNode follows. 
ExpressionGroupNode 
This holds a reference to an ExpressionNode instance, and a boolean indicating whether the 
group is negated or not. 
ExpressionNode 
This class has three fields: property, comparison_operator and value. The property field is an 
instance of PropertyNode, the comparison_operator is any registered comparison operator 
while the value can be literally anything. 
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PropertyNode 
Nodes of this type contains a reference to the property name, the data type returned by this 
property and, in cases where the property returns a collection of an enclosed data type, 
objects of this class will have a reference to the enclosed data type. 
ListSelectionNode 
A node of this type contains an expression to select items from a list. ListSelectionNodes will 
always succeed a PropertyNode with a collection data type, and the condition will be based 
upon the enclosed type of the preceeding PropertyNode. So if the preceding PropertyNode 
has a collection of addresses, the ListSelectionNode will have a condition based on the 
properties of the address class. 
LogicalOperatorNode  
The LogicalOperatorNode contains an instance of a LogicalOperator and is always preceded 
and followed by either an ExpressionNode or an ExpressionGroupNode 
ActionNode 
An ActionNode is used to invoke certain actions supported by the front-end. The ActionNode 
is implemented in order to let the back-end decide when to invoke different front-end 
supported actions.  
UI components 
The Combobox control 
The Combobox control is the most re-used UI component throughout the system. It is a 
flexible, rich, dynamic user interface control that allows for user typing in addition to 
selecting items from a list of possible choices. Several of the UI components described below 
acts as proxies for a Combobox instance by redistributing commands to, and listening for 
changes in it. The Combobox contains an instance of a ComboboxList which consists of 
ComboboxItem instances. A ComboboxItem can have a tooltip text that will be displayed 
when the user points the mouse over it (Figure 13). 
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Figure 13: The Combobox UI Control showing tooltip hints for items matching 
“Tuberculosis” 
 
Each of the expression nodes mentioned in the previous section have their own dedicated UI 
component (Figure 14). For example, the LogicalOperatorNode has a 
LogicalOperatorControl which is responsible for receiving user actions and manipulating the 
LogicalOperatorNode accordingly. All UI components have a getModel-method, which 
returns an instance of the associated token node. The different UI components are described 
below. As the TokenNode superclass, the Control superclass is implemented as a linked list, 
having references to next and previous controls. 
Figure 14: Classdiagram of UI components
ExpressionGroupControl 
This creates an UI control that deal with an expression group. It is responsible for listening to 
user actions and adding new expressions at different points in the hierarchy. An instance of 
this control keeps a reference to the first 
turn, has a reference to the next, and so on.
ExpressionControl 
This control is responsible for a single 
PropertyNavigatorControl, a ComparisonOperatorControl and a Va
responsible for responding to events in these controls, and propagating events upwards in the 
control hierarchy. 
PropertyNavigatorControl 
The PropertyNavigatorControl lets the user navigate and select properties of the current dat
model. It creates a control for every property along the property path, and fires 
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expression (condition). It contains a 
lueSelectorControl. It is 
 
a 
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events based on user actions. 
PropertySelectorControl 
This control is responsible for administering the ComboBox for each of the different 
properties. Whenever the user changes the value of a PropertySelectorControl, an event is 
fired, informing the parent controls about the details of the change in this property. 
ComparisonOperatorControl 
The ComparisonOperatorControl is populated with the valid comparison operators for the last 
property in the current property path. If for instance the property path is: 
employee.address.zipcode 
The ComparisonOperatorControl would contain comparison operators associated with 
numeric values. If the last property is of a complex type, i.e. of the Address type, a 
ComparisonOperatorControl will also contain the properties of this type. Selecting one of 
these properties will cause the control to fire an event, telling the PropertyNavigatorControl 
to add the selected property to the end of the current property path. 
ValueSelectorControl 
This control displays an input-field for the user to type the value to be compared. If a lookup 
is registered for the current data type or property path, the ValueSelectorControl will retrieve 
the list items from the lookup and display them as a list of possible alternatives. The 
ValueSelectorControl can also use a widget for selecting special value-types, for example a 
date. 
XML serializer 
To convert the expression from the internal representation of TokenNodes to an XML 
representation of the expression, the XMLSerializer class was written. 
In order to serialize an expression, a new instance of the XMLSerializer would be created 
with the root-expression as constructor parameter: 
var serializer = new XMLExpressionSerializer(new ExpressionGroupNode(), datamodel) 
52 
 
Then, the serialize-function of the XMLSerializer instance will return an XML document 
object, which in turn can be serialized to a string using the Sarissa XML Serializer. 
var serializer = new XMLExpressionSerializer(app.getModel(), datamodel) 
The XMLExpressionSerializer constructor takes the root-expression as parameter and has the 
two functions serialize() and deserialize() which returns an XML document object and an xml 
string, respectively. See Appendix J for an example of an XML serialized expression. 
Back-end 
An essential part of the back-end implementation is the return-type introspection on property 
get-methods. Introspection features are used when the front-end asks the back-end for a list of 
properties belonging to a given class. Introspection features in the back-end are implemented 
in the Groovy-class TypeExtensions. More specifically, the static method getEndClass in the 
TypeExtensions class will return the return type of the method corresponding to the last 
property in a property path (a string of dot-separated properties, i.e. “employee.address.zip”). 
This is an example invocation of the getEndClass-method: 
// What type does the getName-method of the Patient-class return?  
System.out.println(TypeExtensions.getEndClass(Patient.class, "tribe"));  
 >> class org.openmrs.Tribe 
 
// The getAddresses-method of the Patient class returns a java.util.Set of  
// org.openmrs.PersonAddress instances  
System.out.println(TypeExtensions.getEndClass(Patient.class, "addresses")); 
>> java.util.Set<org.openmrs.PersonAddress> 
  
// What type would be returned if calling  
// emp.getDepartment().getAddress().getZip()  
// on the Employee-object emp  
System.out.println(TypeExtensions.getEndClass(Employee.class, "department. 
location"));  
>> class no.uib.bna049.example.Address 
  
// Projecting across a list  
System.out.println(TypeExtensions.getEndClass(Employee.class,      
"projects.find({it.name.contains('database')}).department.location.zip")); 
>> int 
The getAllMethods method (see Appendix G) returns a list of all methods declared for a 
given class: 
53 
 
System.out.println(TypeExtensions.getAllMethods(Address.class)); 
>>[(...) public void no.uib.bna049.example.Address.setCountry(java.lang.String), 
public java.lang.String no.uib.bna049.example.Address.getStreet(), public void 
no.uib.bna049.example.Address.setStreet(java.lang.String), public java.lang.String 
no.uib.bna049.example.Address.getCity(), public void 
no.uib.bna049.example.Address.setCity(java.lang.String), public int 
no.uib.bna049.example.Address.getZip(), public void 
no.uib.bna049.example.Address.setZip(int), public native int 
java.lang.Object.hashCode(), public final native java.lang.Class 
java.lang.Object.getClass(), (...)] 
Combined, these two methods can give us a list of all methods at the end of a property path: 
Type endclass = TypeExtensions.getEndClass(Employee.class, "department.location");  
List<Method> methods = TypeExtensions.getAllMethods(endclass);  
System.out.println(methods); 
>>[(...) public void no.uib.bna049.example.Address.setCountry(java.lang.String), 
public java.lang.String no.uib.bna049.example.Address.getStreet(), public void 
no.uib.bna049.example.Address.setStreet(java.lang.String), public java.lang.String 
no.uib.bna049.example.Address.getCity(), public void 
no.uib.bna049.example.Address.setCity(java.lang.String), public int 
no.uib.bna049.example.Address.getZip(), public void 
no.uib.bna049.example.Address.setZip(int), public native int 
java.lang.Object.hashCode(), public final native java.lang.Class 
java.lang.Object.getClass(), (...)] 
Please refer to Appendix H for the full implementation of the getEndClass method.   
The BackendController class 
The back-end is written as a Grails controller. A Grails controller-class exposes its defined 
methods as an URL. To illustrate, consider the controller-method “sayhello” in the Groovy 
controller-class HelloWorldController:  
class HelloWorldController {  
    def sayhello = {  
        render "Hello World!"  
    }  
}  
This method is available at the relative server url: helloWorld/sayhello and will display 
“Hello World!” in the browser window when accessed. 
The front-end communicates with different controller-methods according to the lookups 
registered in the front-end. The only one critical and required controller-method is the one 
delivering the list of properties to the front-end. This method takes two parameters – one is 
the property path and the other is the starting-point class (or context). The controller-method 
is then required to return a JSON object with a list of read-methods of the end class and their 
54 
 
return type. 
Delivering other types of data to the front-end 
Several lookups can be defined for the front-end, triggered by a certain path, data type, 
property name or combination of these. For instance, the gender of a person is often 
represented by a "gender" property in a Person-class. The format on the value of this property 
may vary from "M, F" to "Male, Female", "1/0" etc... This format may be unknown to the 
user, and not even standardized in the data model. Therefore it might be useful to query the 
database for a list of all the possible values of the gender property. To achieve this, the 
lookup is added to the register with a matching property name and data type and an 
implementation of the request-function. 
The request-function calls an URL, invoking a back-end controller that looks in the database 
for a list of distinct values for the gender field, and then returns it. 
On the client-side (JavaScript): 
Register.Lookup.add({  
    id: 'gender',  
    property: /.*gender/,  
    datatypes: ['string'],  
    request: function() {  
        new Ajax.Request('backend/json_genders', {  
            evalJSON: true,  
            onComplete: function(response) {  
                var json = response.responseJSON  
                this.respond(json)  
            }.bind(this)  
        })  
    }  
}); 
On the server-side (Groovy controller): 
def json_genders = {  
    response.setHeader('Content-type', 'application/json;charset=UTF-8')  
    render Person.executeQuery("select distinct p.gender from Person p")  
} 
4.3.3 Integration with the OpenMRS API 
Integrating the OpenMRS API with Grails was straight-forward. The OpenMRS API jar file 
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is available for download from openmrs.org, and has built-in object-relational mapping 
through embedded Spring and Hibernate configuration files. 
After the OpenMRS API jar file was downloaded, it was copied to the lib subfolder of the 
Grails project folder. 
The content of the Spring configuration file applicationContext-service.xml was then 
copied from the OpenMRS JAR into the grails-app/conf/spring/resources.xml file. 
The database schema was then created and populated with demo data using sql files available 
for download from openmrs.org. Finally, entering the database login details in the grails-
app/conf/DataSource.groovy file was all the configuration work needed to do in order to 
integrate OpenMRS in the Grails application. 
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5 EVALUATION 
This chapter is divided in two parts. The first part begins by presenting the characteristics and 
purpose of evaluation, followed by a description of the evaluation techniques and design 
utilized in this thesis. The second part presents the findings, and a general discussion of their 
impact. 
5.1 What is an evaluation and why do we do it? 
The purpose of an evaluation is to assess the effects and effectiveness of something, typically 
some innovation, intervention, policy, practice or service (Robson, 2002, p. 202). Evaluation 
can be classified as either being formative or summative. This classification is often used in 
educational sciences where the formative evaluation is used by an instructional designer to 
improve a curriculum or educational programme, while the summative evaluation is at a later 
stage used to assess the outcome of the change in curriculum. The distinction is well 
illustrated in Robert Stakes notable quote "When the cook tastes the soup, that’s formative; 
when the guests taste the soup, that’s summative" (quoted in Scriven, 1991, p. 169). 
Formative evaluation is intended to help in the development of the programme, innovation or 
whatever is the focus of the evaluation, while a summative evaluation “concentrates on 
assessing the effects and effectiveness of the programme” (Robson, 2002, p. 206).  
5.2 Usability evaluation 
Different methods exist for evaluating the usability of a computer system. In a study by Tullis 
and Stetson several different methods for assessing website usability were compared (Tullis 
& Stetson, 2004). This study suggests that the questionnaire yielding most “correct” answers 
at the lowest sample size was the Systems Usability Scale (SUS). At a sample size of only 8, 
SUS gives an accuracy rate at about 75%, while the others stay as low as 40-45%. The SUS is 
a freely available, widely tested and easy to apply questionnaire used to assess the degree of 
usability offered by a computer system. 
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Figure 15: The systems usability scale compared to other available usability measurement 
scales (Tullis & Stetson, 2004)  
SUS is developed as a global assessment scale that can be used to compare usability across 
different contexts. Brooke argues that there is no objective way of measuring usability. For 
example, the ISO 9241-11 standard suggests that usability should be evaluated in terms of 
effectiveness, but “effectiveness are very obviously determined by the types of task that are 
carried out with the system” (Brooke, 1996). Therefore, he claims that comparing two 
different systems is a matter of “comparing apples and oranges”, and that the only possible 
way to do comparable usability assessments across different systems is by using a subjective 
assessment scale (Ibid.). What is measured is how a group of users perceive and judge the 
system in use rather than how the system performs at any given task or property. 
5.3 Evaluation design 
The evaluation of the prototype was performed in two phases. Phase one used a formative 
approach with a desire to find areas of improvement and unveil possible errors. The feedback 
received from this phase was used to guide further improvement of the system. The second 
phase had a summative nature, as the goal was to measure the outcome of the first phase.  
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Although a subordinate goal of this phase was to find areas of improvement, its major aim 
was to answer the question “how well does it work?” (in culinary terms, “how good does the 
soup taste?”). The formative evaluation that followed the development was already described 
in chapter 4, so only the summative evaluation will be presented in this chapter. 
Apart from the evaluation conducted at time of development, the final prototype was 
evaluated by four users with both domain knowledge and technical understanding. These 
evaluations focused on how the users appreciate the proposed prototype, both in terms of 
usability (i.e. ease of use), and its applicability (i.e. its ability to solve the actual problem to 
which it is proposed as a solution). 
Revisiting the description of SUS above, a remark on the type of system is needed. Tullis & 
Stetson (2004) evaluated different methods for assessing website usability. The Eligibility 
Criteria Builder however has more characteristics of an application and to a less extent 
website in the traditional sense. Accordingly, the term “website” may not be an accurate 
description of it (a more precise term will be “web-application”). However, all but one of the 
original methods in this study was originally developed for websites. They served as a means 
to evaluate computer systems in general. They were later adapted by the authors to the 
context of websites (Tullis & Stetson, 2004). The SUS offers a ready-to-use questionnaire 
form in which the user gives an answer according to their degree of agreement to a list of 
statements. 
5.3.1 Questionnaire 
Each evaluator was asked to respond to a questionnaire that accompanied the evaluation e-
mail (see Appendix A). This questionnaire consisted of two parts. Part I was the SUS 
questionnaire and part II a semi-structured questionnaire with questions about previous 
experience with similar systems, and general judgements and comments about the system.  
For part I, the SUS scale, the questions asked were: 
1. I think that I would like to use this system frequently 
2. I found the system unnecessarily complex 
3. I thought the system was easy to use 
4. I think that I would need the support of a technical person to be able to use this 
system 
5. I found the various functions in this system were well integrated 
6. I thought there was too much inconsistency in this system 
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7. I would imagine that most people would learn to use this system very quickly 
8. I found the system very cumbersome/awkward to use 
9. I felt very confident using the system 
10. I needed to learn a lot of things before I could get going with this system 
The questions asked in the second part were: 
1. Experience with other systems 
a) I know of similar systems (Yes/No) 
b) I have used similar system(s) before (Yes/No)  If answer is No, go to d) 
c) I have used these systems before: 
d) I will summarize the major difference between the system(s) I have previously 
used and this as: 
2. Technology 
a) I would like to use a system like this in my own practice (Yes/No) 
b) In what ways, if any, could this system improve your current practice? 
c) What potential advantages, if any, could the use of a system like this have? 
d) What potential disadvantages, if any, could the use of a system like this have? 
e) How can this system be improved in terms of functionality and user friendliness? 
f) Were you able to formulate any tasks from your own practice? If not, what was 
the problem? 
g) General comments, thoughts, etc. 
5.3.2 Evaluation website 
For convenience, an evaluation website was set up and made accessible for the evaluators 
(Figure 16). The site had a login screen, where each evaluator had to type in a pre-assigned 
participant id. When authenticated, they got the choice between solving the practice tasks, 
doing the actual test-tasks as specified in the evaluation guidelines or restarting the session. 
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Figure 16: The Evaluation site, welcome screen after authentication. 
When clicking either the “Start practice” or “Start test” buttons, a new window opens with 
the prototype. To make it easier for the evaluators, the task description were integrated in the 
prototype and would appear when they chose the corresponding task from two added 
dropdown fields (Figure 17). 
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Figure 17: The evaluator selects which task number he/she is about to solve 
5.3.3 Evaluators 
Four evaluators were recruited for the evaluation of the prototype. Ideally, it would have been 
at least twice as many, but it turned out to be quite a challenge recruiting the right people. 
Several relevant mailing lists were inquired, but with rather modest response. Fortunately, we 
managed to get four skilled evaluators with both domain knowledge and technical insight. 
Because the evaluators were situated in different parts of the world (India, Pakistan, Norway), 
communication were done using e-mail.  
After agreeing to participate, the evaluators were sent an e-mail with instructions on how to 
access the evaluation site, perform the evaluation tasks and fill in the attached questionnaire 
(See Appendix A for the whole e-mail). 
5.3.4 Practice tasks 
To make sure the evaluators become familiar with the system and how it works, two test-
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tasks were prepared beforehand. These tasks were based on a simple data-model consisting of 
three classes: Employee, Department and Address (see Figure 18). This data-model was far 
less complex compared to the OpenMRS model and it was intended to give the evaluators an 
understanding of how the prototype works through learning-by-doing. 
 
 
Figure 18: The data model used in training 
Practice task 1 
Inclusion criteria: 
1.1. Working at the Department of Social Anthropology 
1.2. Age is above 24 years  
1.3. Address is somewhere in Norway 
1.4. Job title does not contain “managing”. 
Exclusion criteria: 
1.5. 50 years or younger 
1.6. Working at department of Information and Media Sciences 
1.7. Living outside Norway 
Practice task 2 
Inclusion criteria: 
2.1 Born before fifteenth of May 1976 
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2.2 Working at a department that is located either in Tanzania or in Uganda, but not in the 
big cities of Dar es Salaam or Kampala. 
2.3 Working at a Department whose name contains Faculty 
Exclusion criteria: 
2.4 Current address is outside Tanzania or Uganda 
2.5 Working on a project ended within the last year with “water” in the project name 
5.3.5 Evaluation tasks 
For the evaluation session, the evaluators were given three main tasks and two additional 
tasks. The three main tasks had varying degree of complexity ranging from simple to 
complex. For the additional tasks the user was asked to edit a previously saved task, and to 
think of any criteria that he/she remembered from his/her own practice and try to solve it 
using the system. To give the evaluation a feature of authenticity, all tasks were authentic 
eligibility criteria taken from real-life protocols11 retrieved from clinicaltrials.gov. The main 
assignment was to build an expression for each of the criterion in the evaluation tasks 
described below. 
The evaluation tasks are deliberately chosen on the basis of their level of complexity. 
Choosing only simple tasks would most likely have produced results that would make it easy 
to conclude that the system is well-suited for the given purpose and easy to use. It was a goal, 
however, to identify the upper limits of the system by exposing it to what can be called an 
acid test12. The evaluation targeted on identifying the systems capabilities - what tasks are 
possible to formulate with the system, and what tasks are too complex to formulate it (i.e. to 
find out “where the shoe pinches”). 
Evaluation task 1 
Inclusion Criteria: 
                                               
11
 See Appendix C for a reference to the study prototocols the criteria is taken from 
12
 Originally a notion of determining whether a given metal is gold 
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1.1. Males or females aged greater than or equal to 1 to less than 4 years 
1.2. Known residents of the village of Bancoumana, Mali or its surrounding area 
1.3. Identified as having a malaria infection by blood film examination 
Exclusion Criteria: 
1.4. Convulsions or history of convulsions 
1.5. Known hypersensitivity or allergy to artemisinin derivatives or mefloquine or 
mefloquine chemically related compounds (for example quinine and quinidine) 
1.6. Presence of any known serious chronic disease (e.g. AIDS, sickle cell disease, 
malignancy) 
Evaluation task 2 
Inclusion Criteria: 
2.1 Born before fifteenth of May 1976 
2.2 Age > 1 year 
2.3 Axillary temperature ≥ 37.5ºC and/or history of fever in the previous 48 hours 
without any other evident cause 
2.4 Unmixed infection with P. falciparum of between 250 and 100,000 asexual 
parasites/mm3 as determined by microscopic exam of the thick or thin smear 
2.5 An informed consent obtained from the patient or his/her guardian (in case of patients 
≤ 18 years old) and assent for children (8-18 years old) 
Exclusion Criteria: 
2.6 Other severe chronic diseases (e.g., cardiologic, renal, or hepatic diseases; HIV/AIDS; 
severe malnutrition) 
2.7 History of allergy to mefloquine, artesunate, quinine, tetracycline, or clindamycin 
2.8 Pregnancy (based on urine test), since this group of patients receives other drugs for 
malaria treatment in accordance with Peruvian national guidelines. 
Evaluation task 3 
Inclusion Criteria: 
3.1. Aged 1 to 5 years 
3.2. HIV infection (previously confirmed by 2 ELISAs for children > 18 months; DNA 
PCR for those < 18 months) 
3.3. Informed consent from the parent/caretaker 
3.4. Ability to return for follow-up (lives within a radius of 15 km from hospital and 
unlikely to change residence during the course of the study) 
Exclusion Criteria: 
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3.5. Children already enrolled in other studies 
3.6. Children with severe abnormalities which are likely to impair oral intake (for 
example, severe cerebral palsy) 
3.7. Severely ill children requiring urgent admission and resuscitation 
Additional tasks 
Load the first test task’s Inclusion criteria for editing and change it so that only females are 
included in this study. Save the expression again when you are done. 
Can you think out some tasks that you experienced in your practice and express it using the 
system? If you do, you can save it as “My task #”. If you encounter difficulties or were 
unable to accomplish it, please write a short note about it in the attached questionnaire. 
5.3.6 Data collection 
Questionnaire response and a log of the solutions to the tasks by the evaluators constitute the 
data that was collected in this thesis. In addition, as one of the evaluators was located in 
Bergen, this evaluator was observed while performing the evaluation tasks. The notes taken 
during this observation session are discussed at the end of this chapter. It would also have 
been interesting to verify the performance and validity of the criteria formulated by the 
evaluators by running them against a real-world clinical trial database and comparing the 
returned patients with the ones that was actually judged (by clinicians) as eligible for the trial. 
This was however not possible as no such database was available. Nevertheless, in order to 
be able to analyze the answered solutions, a collection of example (reference) solutions was 
made beforehand. Comparing these solutions to the solutions given by each evaluator 
provided information about the extent to which the evaluators used the system the way they 
were expected to.  
5.4 Findings 
In this section, the collected data are presented and analyzed. First, response to the 
questionnaire is presented, followed by a summary and analysis of the tasks as they were 
solved by the evaluators. Finally an analysis of the field notes taken in the observation 
session is further elaborated. 
66 
 
5.4.1 Response to questionnaires 
Part I: SUS 
In the SUS part of the questionnaire, each question was given a score between 1 and 5 where 
1 was “strongly disagree” (SD) and 5 were “strongly agree” (SA). A score of 2 is further 
classified as “disagree”, a score of 4 is “agree” and a score of 3 is “neutral”.  The responses 
given by the test-users are presented in Table 1. The numbers to the right of each question in 
represent the number of evaluators that answered by putting the mark in this column. See 
Appendix B for the raw response data. 
Table 1. How the Participants Responded to the Systems Usability Scale13 
  Part I: SUS  SD        SA 
  1 2 3 4 5 
1 I think that I would like to use this system frequently       1 2 
2 I found the system unnecessarily complex 
 
2 
 
2 
 
3 I thought the system was easy to use 
 
2 
 
1 1 
4 I think that I would need the support of a technical person to be 
able to use this system 
 
4 
   
5 I found the various functions in this system were well integrated 
   
2 2 
6  I thought there was too much inconsistency in this system 2 1 
 
1 
 
7 I would imagine that most people would learn to use this system 
very quickly 
 
1 2 1 
 
8 I found the system very cumbersome/awkward to use 
 
3 
 
1 
 
9 I felt very confident using the system 
  
2 2 
 
10 I needed to learn a lot of things before I could get going with this 
system     2 2   
As seen in Table 1., all the evaluators that answered question one (all except one, who left 
this question blank) agreed to the claim that they would like to use the system frequently. 
Two answered that they strongly agreed, while the last evaluator gave this claim a score of 4 
(agree).  
Two of the evaluators found the system too complex to use, while the other two disagreed to 
                                               
13
 Please note that one evaluator did not answer question 1 
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this claim. The reason for this disagreement may be due to differences in knowledge about 
the OpenMRS data model. 
One evaluator strongly agreed to the claim that the system was easy to use, one agreed and 
two others disagreed to this. All disagreed to the claim that they would need help from a 
technical person to use the system, but at the same time two of these evaluators also 
disagreed to the claim that the system was easy to use. Hence, their appreciation of the 
system may be summarized as “it is easy to understand how it works, but it is not so easy to 
use it”. 
All evaluators either agree or strongly agree to the statement that the various functions of the 
system were well integrated. While one of the evaluators agreed to the statement that there 
was too much inconsistency in the system, the three others either disagreed or strongly 
disagreed to this claim. 
To the claim that most people would learn to use the system very quickly, the views differed. 
One agreed to this, another one disagreed while the two others answered neutral to this. In 
this question, the evaluators were actually asked about how quick they think other users will 
learn how to use the system. It is clear, however, that with the fairly short explanation of how 
the system works and the usage example attached in the evaluation e-mail, it is evident that 
all of the evaluators managed to learn the basic usage (by solving at least some of the tasks 
properly). Whether most other people would learn to use the tool as quickly as the evaluators, 
is, however, remains an open question. 
Three evaluators strongly disagreed that they found the system very cumbersome/awkward to 
use, while the last one agreed to this claim. Two evaluators agreed that they felt confident 
using the system, while the other two gave neutral answers to this claim. Also, two evaluators 
agreed that they needed to learn a lot of things before using the system, while the other two 
answered neutral. The different answers to these questions may be attributed either to 
different levels knowledge of, and experience with the OpenMRS data model, or to different 
levels of programming experience by the evaluators.  
Part II: Experience with other systems & technology 
To the questions about experience with similar systems, only one of the participants answered 
that they had knowledge of a similar system, and named the OpenMRS cohort builder as one 
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of which he had previous experience. When asked to compare the previously used system 
with the Eligibility Criteria Builder, this evaluator stated that: 
 “This system can search for very, very specific information; at a far greater depth than 
Cohort Builder.” [Evaluator 2] 
All but one of the participants answered that they would like to use a system like this in their 
own practice. One evaluator left this question unanswered. When asked whether and how the 
Eligibility Criteria Builder could improve their current practice, the views differed. One of 
the participants viewed the prototype as a handy query tool that could speed up the process: 
It could allow clinicians in our organization to quickly find patients matching very specific 
criteria. This of course could expedite the entire process of analysis. [Evaluator 2] 
Another participant envisioned other uses for a tool like this, not only limited to selecting 
eligible participants to a clinical trial. 
It would be useful if the system could import a user specified dictionary so that it could 
adapted for developing Inclusion & Exclusion criteria for any type of selection procedure, 
not just in medicine. [Evaluator 3] 
A viewpoint by another evaluator is that just having computerized eligibility criteria 
represents a great improvement alone: 
“By forcing the eligibility criteria to be defined so that they can also be computerized.” 
[Evaluator 1] 
To the question about the potential advantages, if any, of the use of a system like the 
Eligibility Criteria Builder, the first evaluator judges the tool as something that can ensure 
adherence to the protocol: 
“It ensures that the protocol is adhered to” [Evaluator 1] 
The second evaluator re-emphasized the statement from the previous answer, and upheld the 
view of the prototype as a query tool: 
“Again, allowing one to find highly specific information quickly. “ [Evaluator 2] 
The third evaluator sees it as a tool to develop selection criteria for all types of surveys that 
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require a population sample: 
“To quickly develop selection criteria for all sorts of sample surveys” [Evaluator 3] 
The general purpose of the prototype is also clearly understood by the last evaluator: 
This system could help in ensuring that data collected conforms to predetermined conditions 
thereby reducing errors. [Evaluator 4] 
When asked about the potential disadvantages the use of a system like the Eligibility Criteria 
Builder could have, the second evaluator indicated that one of the earlier mentioned strengths 
of the system could also be a weakness because of the domain knowledge it requires from the 
user: 
“Because it can be so specific, only people with specialized knowledge in that field could 
operate the system.” [Evaluator 2] 
Another evaluator suggests that the user should be able to add domain-specific dictionaries to 
the system, through the user interface. 
Domain-specific dictionaries should be possible to add to the software by the user. 
 [Evaluator 3] 
This is clearly an interesting point, but also relies heavily on the vocabulary structure 
implemented by the underlying data model. An interface should ensure that whatever 
domain-specific terms that will be added by the user at the criteria definition stage will be the 
same terms later used at the data entry stage. It is also worth noting that the infrastructure for 
knowledge modelling may already be available in the existing software. 
Another response to this question by the same evaluator could be classified as a missing 
feature rather than a potential disadvantage of using a system like this: 
This system does not point out errors in the expressions. [Evaluator 3] 
It is nevertheless an important comment, and this missing feature should receive attention in 
any future version. 
Another potential disadvantage of using a system like this is mentioned by another evaluator: 
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“It may lose some of the flexibility and medical based decisions.” [Evaluator 1] 
This is a problem if a tool like the Eligibility Criteria Builder would be used uncritically to 
automatically enrol patients into a clinical trial. The tool should however not be used this 
way. It should rather suggest to the user a list of potentially eligible patients recommended 
for participation. Each patient should ultimately be approved based on a qualified judgement 
by a clinician. 
The fourth evaluator answers this question from a usability perspective pointing to an 
inherently restrictiveness and inflexibility in the system (without any further elaboration). 
It might be too restrictive and inflexible for the end user. [Evaluator 4] 
Each evaluator was also asked about how the system could be improved in terms of 
functionality and user friendliness. To this question, one evaluator answered: 
It would help if the system permitted me to edit the Code for the expressions directly as that is 
sometimes required for better control. [Evaluator 3] 
This is to be considered an advanced feature for expert users with programming skills. 
Because the user interface was designed to enable non-programmers to define the selection 
criteria, the possibility of “programming” the criteria code was not prioritized. If there would 
be any future development of the prototype, this should however be considered as an 
interesting feature as it will enable extremely powerful expression formulation. This 
evaluator also adds another interesting remark: 
Errors in expressions should be highlighted so that they can be easily corrected.  
[Evaluator 3] 
The user interface of the Eligibility Criteria Builder is designed to prevent (or at least limit) 
syntactical errors from occurring as it forces the different parts of the expression to be 
selected from a set of valid choices. Nevertheless, the system still allows for errors to be 
typed, so this evaluators point is important. It would be a critical requirement provided the 
code edit feature described above was to be implemented. Errors in the formulated criteria 
can potentially have an enormous impact on both the safety of the involved patients and the 
outcome of the study. 
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Another improvement was suggested by another evaluator: 
When setting conditions (ex: where [concept is CDC CATEGORY C] ) another window 
opens, but when setting conditions in there, yet another window can open, this time right on 
top of the first, making it hard to distinguish between the two. This should be resolved. 
[Evaluator 2] 
This is a very interesting remark that also has an easy technical solution. As an effect of this 
issue, rather than get the impression of a new window opening, the user might just as well 
perceive it as the fields in the current window gets blanked out. A workaround for this issue 
would be to adjust the position of newly opened window in the bottom-right direction. Thus, 
the background window would appear more clearly as layered behind the newly opened one. 
This evaluator has another suggestion for improvement: 
Also, I would like to be able to search for terms within concept descriptions (ex: selecting a 
concept that contains the word “chronic” in the description). [Evaluator 2] 
This feature is actually supported. For example, when searching for “chronic”, the system 
returns the concept “Asthma”, which has “chronic” among the words in the description but 
not in the title. This is a feature that is supported by the backend implementation, as it is the 
one that receives the search term from the user interface, processes it and decides what 
elements to return. The fact that the evaluator did not realize this may however indicate that 
this feature should be clearer to the user. 
Here is another suggested improvement: 
In this setup, the major limiting factor is the fact that it uses the OpenMRS API, which to 
people not familiar with it, is complex. But a person knowing OpenMRS would very quickly 
be able to complete these steps. [Evaluator 1] 
This comment is not directly concerning the prototype itself, but the data model used to test 
it, and the familiarity of it by the users. The OpenMRS data model is complex, but on the 
other hand, it is also realistic as a candidate data model for use with the system. The 
prototype should be able to handle complex data models, without sacrificing usability. It 
would, however be reasonable to expect clinicians responsible for the clinical trial to have at 
least some familiarity with the data model. 
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It was also suggested that the system should be clearer on the semantics of the different fields 
(properties) that was made available for user selection. 
Provide more meaning and consistence to the fields in the system. [Evaluator 4] 
For example, there is no way of knowing what the property “accessionNumber” of the 
observation class means, unless the user has detailed knowledge about the underlying data 
model. This point is returned to in the future work section (6.2) in chapter six. 
None of the evaluators were able to formulate tasks from their own practice (even though one 
of the evaluator answered “Yes” to this question, no custom tasks were saved for this user). 
One of the participants ran into connectivity problems while testing and the two others did 
not have any available criteria to test. 
In the final open-ended question, the evaluators were given the opportunity to write down 
their general comments and thoughts about the system. This is how they responded: 
If integrated into OpenMRS (not just as a module), then it could easily replace the Cohort 
Builder. I liked how you can search from general demographics down to the most specific 
observations. [Evaluator 2] 
This participant suggests that the prototype could be used instead of the Cohort Builder in the 
OpenMRS client system. This suggestion was passed on to one of the lead-developers of 
OpenMRS, which responded positively. Due to time constraints, this was however not 
explored this time. Further exploration of this should certainly be a part of any future work 
and should involve cooperation with the OpenMRS developers. 
A nice tool that could be generalized for developing selection criteria for a wide variety of 
applications [Evaluator 3] 
Again, this participant views this tool as a more general purpose tool for creating logic 
expressions that can be used in other types of applications. 
This is a very interesting project, and I look forward to seeing the outcomes of it. 
[Evaluator 1] 
The evaluator that did not have any previous experience with- or detailed knowledge of- the 
OpenMRS data model, emphasized the need for a more though trough user interface. 
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More thoughts need to be given to develop a more user-friendly view of the data. 
 [Evaluator 4] 
5.4.2 Analysis of the solutions by the evaluators 
In this part, I will compare the user-solved tasks with my reference solutions. The goal of this 
analysis is not to compare the user tasks with an alleged “correct solution” (as there can be 
many), but rather to learn how the users actually use the prototype by identifying the level of 
similarity or dissimilarity between the expressions formulated by the test users and the 
expressions that was formulated on beforehand. 
The tasks solved by the evaluators had varying degree of similarity with the reference 
solutions. Some tasks were almost identical, while others had little or no resemblance at all. 
Please refer to Appendix D for a complete list of the evaluators’ solutions to the different 
tasks. The level of similarity with the reference solutions is classified in five categories: 
o High (high degree of similarity with the reference solution) 
o Medium (part of the answer is correct) 
o Low (little resemblance with the reference solution) 
o Error (invalid due to a bug with the system) 
o Missing (left blank) 
Table 2. Overview of how Evaluators Solved the Different Tasks 
  Evaluator 1 Evaluator 2 Evaluator 3 Evaluator 4 
Task 1 Inclusion High High High High 
Exclusion Error Error High Error 
Task 2 Inclusion High Medium Missing Low 
Exclusion Error Error Missing Error 
Task 3 Inclusion Error Error Missing Low 
Exclusion Missing Low Missing Low 
 
As shown in Table 2., six of in total 24 tasks were solved with a high degree of similarity to 
the reference solutions. All of the evaluators succeeded in solving the first inclusion task. For 
the first exclusion task, the prototype failed in saving the task properly due to an error. As an 
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unfortunate consequence, the solution became corrupted as one part of the expression 
repeatedly constituted the whole expression (see Appendix D - evaluation task 1, exclusion 
criteria 2 by evaluator 2 and 4). This error in the prototype was not discovered before the user 
tasks were loaded for analysis long after the evaluation session was ended. Evaluator 3 saved 
each criterion as a separate task, and thereby avoided this error. 
Out of the 24 tasks, five were intentionally left completely unanswered. One evaluator alone 
accounts for four of the missing five tasks. It is reasonable to believe that the corrupted tasks 
were to at least some extent solved properly. In total, nine of the tasks were left blank or had 
a low degree of resemblance with the reference task. This can be explained as due to several 
factors: 
o The complexity of the data model 
o Poor usability provided by the prototype 
o The complexity of the tasks 
The OpenMRS data model is complex. It is a result of 30 years of experience with the 
Regenstrief Medical Record system (Mamlin, et al., 2006). Even though the prototype 
connects with and reads meta-information about the OpenMRS API (which hides much of the 
complexity of the underlying relational data model), the OpenMRS API as the user interacts 
with is still complex and unintuitive to a non-programmer. This was especially brought to 
light under the observation of evaluator 4 (see 5.4.3) which in particular found the API 
difficult to navigate in. 
The complexity of the data model can also affect the usability as experienced by the 
evaluators. As stated by Evaluator 4, the high number of properties to each class (many of 
which did not make any sense, e.g. the “attributeMap” attribute), was somehow confusing 
and made navigation more difficult. 
Due to the reasons given in section 5.3.5, some of the tasks were chosen intentionally because 
of their high degree of complexity and this in spite of the awareness that they would most 
likely be impossible to formulate using the prototype. Facing these seemingly invincible tasks 
may have been a motivation killer. 
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5.4.3 Observation session 
This section presents an elaboration of field notes taken while observing one of the evaluators 
performing the given evaluation tasks. 
At first, the evaluator had trouble knowing what properties to select from the dropdowns. He 
was not too familiar with the OpenMRS data model, and did not know where the information 
he wanted to use in the expression was located. With some help, he quickly learned that most 
of the useful information (except more primitive attributes like year, age, etc) was located at 
“observations  [where concept is ...]valueAs(...)”. This was clearly perceived as non-
intuitive to him. So his first impression was that this tool was very confusing and it was 
difficult to know where to look for the exact properties. He also suggested that there were too 
many options, leading to even more confusion. For example, if one wants to set an expression 
by selecting the [observation where concept is PREGNANCY STATUS] of which the answer 
is represented in the valueAsBoolean property, all the other properties of the concept data 
type appeared as choices. In this case, valueAsBoolean should appear as the only valid option 
for the user.  This is however a result of that the tool is designed to be generic. A probable 
“solution” to this problem would be to add a mechanism to easily add internal data model 
constraints of which the interface could make use. 
The evaluator also suggested that the criteria chosen for evaluation tasks were highly 
complex, that real world eligibility criteria were usually less complex. Also, he remarked that 
OpenMRS was maybe not be the best suitable data model as it would be more realistic if the 
prototype were connected to a data model of a specific study and tested by having the 
evaluators formulating the exclusion inclusion criteria for that specific study – implicating 
that the chosen criteria was not “compatible” with the chosen data model. He also said that 
the evaluation task 3.4 “Ability to return for follow-up” is impossible represent in the system. 
This would typically be a judgement by the clinical worker, and recorded in the database 
using a case report form (CRF). This information was, however represented as a concept in 
the database used in evaluation, but evidently perceived as inaccessible to the user. 
5.5 Final words on evaluation 
Retrospectively, it is easy to see that the evaluation would have had a much more realistic 
character if tested against a database designed specifically for a clinical trial, including both 
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basic patient data demographics, journal history, electronic CRFs etc. It is worth mentioning 
that a clinical trial may also take advantage of a generic database/data model like OpenMRS, 
so it may not be unthinkable that this type of comprehensive data model integrated with the 
Eligibility Criteria Builder. However, most of the problems experienced by the observed 
evaluator can be attributed to the complexity of the OpenMRS data model, not the prototype 
itself. 
As it turned out to be more difficult than first anticipated to find qualified evaluators, the 
research performed in this thesis is far from complete. In order to give a qualified judgement 
of the prototype, its applicability and usability, a greater number of evaluators should have 
been used for the evaluation. In particular, the Systems Usability Scale (SUS) performs at its 
best using a sample size of eight evaluators. At a sample size of four, it actually performs 
slightly worse than its contestants (Figure 15). Thus, for the usability evaluation, it is 
impossible to give any clear conclusions. A conclusion regarding the open-ended questions 
about the technology (pt. 2 in the second part of the questionnaire) is neither easy to draw on 
the basis of such a small sample group. A few general points can however be extracted from 
the questionnaire and observation session combined: 
o None of the evaluators had knowledge of similar systems14 
o All but one of the evaluators would like to use this system in their own practice15 
o The prototype has room for improvements on the usability side 
o The high complexity level of the OpenMRS data model used in the evaluation 
possibly made it more difficult to formulate the tasks as expressions than necessary 
o The eligibility criteria chosen for the evaluation was possibly more complex than they 
usually are in real-world clinical trials  
So, what can be said on the basis of feedback from four users? It is possible to use the data 
material presented above and the experience gained through the development of this 
prototype to give directions to further development and research, which is presented in the 
next chapter.  
                                               
14
 One of the evaluator mentions OpenMRS Cohort builder as a similar system, but as argued 
in section 2.2 and 2.6, both the implementation and purpose of this is different than of the 
Eligibility Criteria Builder 
15
 One of the evaluators left this question blank 
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6 CONCLUSIONS AND FUTURE WORK  
The research question for this thesis was “How can a data model independent software tool 
be developed to support users to formally define criteria for patient eligibility in a clinical 
trial”. In order to answer this question, a generic, data model independent prototype 
(Eligibility Criteria Builder) was developed. For evaluation purposes, it was connected to the 
comprehensive OpenMRS data model. The prototype was evaluated with four different users 
with both technical and domain knowledge. For the evaluation, eligibility criteria from real-
world clinical trial protocol were used. These criteria varied in complexity, from simple (i.e. 
“age less than 18”) to complex (i.e. “HIV infection (previously confirmed by 2 ELISAs for 
children > 18 months; DNA PCR for those < 18 months)”). The evaluation indicated that the 
prototype may have been well suited to formulate less complex tasks, while the more 
complex criteria posed a greater challenge to the users. This can, however, to some extent be 
attributed to the choice of using the complex OpenMRS data model in the evaluation phase. 
The project was in general viewed as an interesting and important project by the evaluators 
and almost all of them stated that they would like to use the system in their own work. There 
were different opinions about the ease of use and complexity of the system, indicating that 
further improvements are needed. Comparing the proposed solutions by the evaluators 
suggests that familiarity with the OpenMRS data model influenced the successful use of the 
system. This further indicates that the complexity of the data model has an impact on the 
usability of the system. 
Both the literature study and feedback from the domain experts and the evaluators suggest 
that the need for a system like the Eligibility Criteria Builder is clear and present and an 
automated way of determining patient eligibility for a clinical trial can improve both 
efficiency and safety of clinical trials. The time spent identifying eligible patients in today’s 
paper based regime is significant, and thus has a great potential for improvement. The safety 
of patients is not automatically ensured by using a computerized system alone, but can be so 
as a consequence to the fact that it promotes the definition of more formal and unambiguous 
eligibility criteria. 
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6.1 Reflection 
Retrospectively, it is clear that a simpler data model should be used during evaluation. The 
complexity of the OpenMRS data model posed a great challenge to the evaluators, and most 
likely also influenced their appraisal of the usability of the system. If a simpler, yet more 
intuitive data model was used as the basis for expression formulation, this situation may have 
looked different. The data model used during evaluation was the OpenMRS API, which is a 
simplification of the underlying relational database schema. However, the purpose of the API 
is to provide the programmers a more efficient way of accessing data after they are extracted 
from the database. Thus, the API is designed for efficacy purposes and not as a means to 
describe the data model in terms of concepts and their relations. For this purpose, an ontology 
specification of a clinical trial may have represented a better subject data model for the 
Eligibility Criteria Builder. As the prototype is developed as a generic tool, there are, 
however, no restrictions in the prototype that prevents it from being connected to ontology 
with little effort. 
Due to the errors in some of the tasks saved by evaluators, it is also evident that more time 
should have been spent on error detection and bug fixing. Unfortunately, this error was not 
noticeable to the user during the evaluation session and was therefore not discovered until  
much later, when the solved tasks were extracted from the database for analysis. 
The number of evaluators should ideally have been twice as large. As the Systems Usability 
Scale outperforms its peers at a sample size of eight, at least this many users should have 
participated in the usability evaluation. With a minimum of eight test users, it would have 
been possible to draw conclusions based on the response to the SUS questionnaire with 
greater confidence. The evaluators were primarily technologist with a high level of clinical 
trial domain knowledge. In order to get a better picture on how clinicians with no or little 
technical competence would judge the system, a representative group that better matches the 
target user for the prototype should be recruited. 
It is also important to reflect on possible unforeseen consequences of using formally defined 
eligibility criteria to automatically select eligible patients for a clinical trial. Could there be 
consequences that may even lead to reduced safety for patients? What if an important 
criterion is missing or left out unintentionally and not discovered? This can certainly be a 
problem even without a computerized system, but if the eligibility determination is fully 
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automated (i.e. no clinician involvement), such flaws may have less likelihood of being 
discovered. Therefore, an emphasis on the importance of human involvement is needed. The 
Eligibility Criteria Builder should never be used to completely automate the enrolment 
process, but rather as a means to increase the efficiency and reduce the resources needed to 
determine eligibility of each individual potential participant in a clinical trial.  
6.2 Future work 
There is a long way to go before the proposed prototype could be made available for 
production use. 
The more general and technical improvements should receive more focus in future 
development. In particular, the specific issues and areas of improvement disclosed during 
evaluation should be prioritized (e.g. the dialog window issue as reported by one of the 
evaluators). A point given by one of the evaluators highlights the importance of better error 
checking facilities and feedback from the system if inconsistencies occur. Also, improved 
constraints between properties, data types and valid values (as pointed out by another 
evaluator) should receive attention in further development. This could be achieved by 
implementing an extended data model description format. 
As it was suggested to view the Eligibility Criteria Builder as a possible future replacement 
of the OpenMRS Cohort builder, exploring this possibility should also receive more attention 
in the future. 
As one of the challenges with this system was the complexity of the data model, a more 
intuitive data model should be used as the subject data model to which the prototype is 
interacting in such an evaluation. In particular, using an ontology as the underlying data 
model would be a very interesting approach to explore in the future.  
Because of lack of access to a database with real patients that actually were recruited to a 
real-world clinical trial, it was not possible to assess the validity of the answers given by the 
evaluators. Thus, another important future aspect would be to examine the quality of the 
expressions produced by the users using the system. To what extent are the right patients 
identified with help of the computerized criteria created by using the system? Finding the 
answer to this would require a thorough study in real-world clinical trials that compares the 
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group of patients selected using computerized eligibility criteria versus the group of patients 
actually enrolled by clinicians in the trial. Only then will it be possible to uncover the real 
utility and value of the Eligibility Criteria Builder. 
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APPENDIX A. THE EVALUATION E-MAIL AND INSTRUCTIONS 
E-mail template 
 
Evaluation guidelines.pdf 
 
1 EVALUATION GUIDELINES 
Thank you for taking interest in evaluating the The Eligibility Criteria Builder Prototype. 
The evaluation is expected to take between 1 ½ to 2 hours to complete. 
2 PREREQUISITES 
Dear <NAME>, 
 
Thank you for taking interest in evaluating the The Eligibility 
Criteria Builder Prototype. 
 
Please follow the instructions in the attached Evaluation 
Guidelines PDF document. 
When done, please return a filled-in version of the Questionnaire 
document. 
 
If you have any problems opening the files or web-address, or 
encounter any problems 
during testing, please let me know immediately. 
 
Your participant id is: <PARTICIPANT-ID> 
 
Best regards, 
Bjørge Næss 
 
Master student at Department of Information Science and Media 
Studies 
University of Bergen (UoB) 
www.infomedia.uib.no 
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In order to test the prototype, you will need a working internet connection and Mozilla 
Firefox version 2.0 or higher installed on your computer. 
3 GETTING STARTED 
Open Mozilla Firefox and go to the address http://ecbuilder.dyndns.org 
Enter your four-digit participant id that you received in the e-mail along with this 
document. Now, you will see three different buttons: “Start practice”, “Start test” and 
“Restart session” 
To get to know the prototype and how it works, click “Start practice” and continue with 
the practice tasks listed below. You can consult the documentation at any time by clicking 
on the “Documentation” button on the toolbar. Section 3 in the Documentation explains 
how to create your first criteria expression. 
3.1 Practice tasks 
Create a new expression for each of the following criteria. 
NOTE: Create a separate expression for each task’s inclusion and exclusion criteria, and 
don’t forget to save each expression before you continue. 
1. Practice task #1 
Inclusion criteria: 
1.1. Working at the Department of Social Anthropology 
1.2. Age is above 24 years  
1.3. Address is somewhere in Norway 
1.4. Job title does not contain “managing”. 
Exclusion criteria: 
1.5. 50 years or younger 
1.6. Working at department of Information and Media Sciences 
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1.7. Living outside Norway 
2. Practice task #2 
Inclusion criteria: 
3.1. Born before fifteenth of May 1976 
3.2. Working at a department that is located either in Tanzania or in Uganda, but not 
in the big cities of Dar es Salaam or Kampala. 
3.3. Working at a Department whose name contains Faculty 
Exclusion criteria: 
3.4. Current address is outside Tanzania or Uganda 
3.5. Working on a project ended within the last year with “water” in the project 
name 
When you are done, remember to save the last expression before you close the window 
and go on with the actual test by clicking on the “Start test” button. 
3.2 Test tasks 
These are authentic eligibility criteria taken from real clinical trial protocols. The first task 
contains criteria from different protocols, while task two and three are from 1 and 1, 
respectively. 
3.2.1 Read this first 
We are now moving away from Employees, departments and projects, and over to the 
Patient context. You will now work on the OpenMRS data structure and some basic 
information about its different parts follows ("OpenMRS Wiki," 2008): 
• Encounter: A single, specific interaction between the patient and the provider. An 
encounter can be any interaction, including doctor visits, home visits, counselor 
appointments, etc. Encounters are typically represented as a form, consisting of 
hundreds of observations. 
• Observations: Anything actively measured or observed during an encounter. As 
an example, patients’ weights, heights, blood pressures, and BMIs are 
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observations, as well as qualitative facts including the number of years a patient 
smoked, the activities in which the patient experiences shortness of breath, and 
finding on an X-ray. Although typically an observable question, demographics are 
an exception, and are recorded as separate concepts. 
• Concepts are the individual data point collected form a population of patients. 
Concepts include both questions and answers; for example, the question of blood 
type is a possible concept, but the responses, “A”, “B,” & “O” would be 
considered concepts as well. The bottom line is, if you have a medical concept of 
any sort, and it’s needed within your records system, it needs to be defined within 
the dictionary. 
The patients’ observations are where to look for medical information about a patient. 
Every patient has a list of observations, and each observation has a concept and a value. 
According to the type of concept, the value contains the recorded information. If the 
concept is a question, the value contains the answer to that question. If the concept is a 
measurement of height, the value contains the height as a numeric value. Some concepts 
has a list of possible values associated with it. For example, the concept CLINIC 
TRAVEL TIME, which refers to a question on an encounter form asking "How long did it 
take you to travel to clinic today?" has four other concepts as valid answers: LESS THAN 
30 MINUTES, ONE TO TWO HOURS,  30 TO 60 MINUTES or MORE THAN TWO 
HOURS. 
The concept PREGNANCY STATUS, referring to the question “Is the patient pregnant?” 
is of data type Boolean and therefore it has only two valid answers: True or False. 
Depending on the type of observation concept, the value is located in valueCoded (for 
concept answers), valueNumeric (for observations requiring a numeric value), 
valueAsBoolean (for most observations that determines a diagnosis or yes/no questions), 
valueDrug (if the concept is a drug) and valueDatetime (where a certain date is recorded) 
for the observations. 
For the CLINIC TRAVEL TIME question, requiring the answer to be ONE TO TWO 
HOURS will be formulated as: 
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observations [where concept is CLINIC TRAVEL TIME] valueCoded is ONE TO TWO 
HOURS 
In the prototype, this expression would look like: 
Because patients have multiple observations, [where (…)] is used to single out the exact 
observation we want to use in the expression. 
If the patient must be pregnant, the expression will look like: 
observations [where concept is PREGNANCY STATUS] valueAsBoolean is true 
In the prototype, this would be: 
The test tasks are listed below. Please formulate each task’s inclusion and exclusion criteria 
separate from each other, and remember to select the correct task name from the list. 
Note: If you find any of the criteria too difficult to formulate, you can always save it and go 
on with the next, but if you do so, please leave a comment in the Textual description field. 
1. Test task #1 
Inclusion Criteria: 
1.1. Males or females aged greater than or equal to 1 to less than 4 years1 
1.2. Known residents of the village of Bancoumana, Mali or its surrounding area1 
1.3. Identified as having a malaria infection by blood film examination1 
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Exclusion Criteria: 
1.4. Convulsions or history of convulsions1 
1.5. Known hypersensitivity or allergy to artemisinin derivatives or mefloquine or 
mefloquine chemically related compounds (for example quinine and quinidine)1 
1.6. Presence of any known serious chronic disease (e.g. AIDS, sickle cell disease, 
malignancy)1 
2. Test task #2 
Inclusion Criteria: 
2.1. Age > 1 year 
2.2. Axillary temperature ≥ 37.5ºC and/or history of fever in the previous 48 hours 
without any other evident cause 
2.3. Unmixed infection with P. falciparum of between 250 and 100,000 asexual 
parasites/mm3 as determined by microscopic exam of the thick or thin smear 
2.4. An informed consent obtained from the patient or his/her guardian (in case of 
patients ≤ 18 years old) and assent for children (8-18 years old) 
Exclusion Criteria: 
2.5. Other severe chronic diseases (e.g., cardiologic, renal, or hepatic diseases; 
HIV/AIDS; severe malnutrition) 
2.6. History of allergy to mefloquine, artesunate, quinine, tetracycline, or clindamycin 
2.7. Pregnancy (based on urine test), since this group of patients receives other drugs 
for malaria treatment in accordance with Peruvian national guidelines. 
3. Test task #3 
Inclusion Criteria: 
3.1. Aged 1 to 5 years 
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3.2. HIV infection (previously confirmed by 2 ELISAs for children > 18 months; 
DNA PCR for those < 18 months) 
3.3. Informed consent from the parent/caretaker 
3.4. Ability to return for follow-up (lives within a radius of 15 km from hospital and 
unlikely to change residence during the course of the study) 
Exclusion Criteria: 
3.5. Children already enrolled in other studies 
3.6. Children with severe abnormalities which are likely to impair oral intake (for 
example, severe cerebral palsy) 
3.7. Severely ill children requiring urgent admission and resuscitation 
4. Additional tasks 
Load the first test task’s Inclusion criteria for editing and change it so that only females 
are included in this study. Save the expression again when you are done. 
Can you think out some tasks that you experienced in your practice and express it using 
the system? If you do, you can save it as “My task #”. If you encounter difficulties or were 
unable to accomplish it, please write a short note about it in the attached questionnaire. 
When done, please open the attached questionnaire and answer the questions. 
5. References 
OpenMRS Wiki. (2008).   Retrieved 22th of october, 2008, from 
http://openmrs.org/wiki/Dictionary_101 
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Project background.pdf 
 Project background 
Testing the effects of a new treatment involves exposure of the treatment to a group of 
patients. These patients are a subset of a greater group of participants, where the subset is 
selected based on certain eligibility criteria. These criteria are traditionally expressed in 
natural language in its own section in a protocol. The protocol is a document written 
before the study is carried out. It describes the planned study in detail and acts as a 
guideline to all parties involved in the study. The eligibility criteria section can contain 
both inclusion and exclusion criteria. The inclusion criteria are a list of conditions each 
and every patient must meet in order to be enrolled in the study (i.e. the patient is 
diagnosed with the disease the treatment is supposed to treat). Similarly, the exclusion 
criteria list conditions that would disqualify the patient for enrolment in the study (i.e. a 
known allergic reaction to the medicine in question). 
When a clinical trial is carried out, the eligibility criteria are used to enroll new patients in 
the study. This is done by cross-checking medical records for every patient against each 
criterion. Some large-scale clinical trials need up-to 3000 eligible patients (and a 
considerable bigger group of potential participants). So, in consequence the patient 
selection is a highly extensive and time-consuming task. 
Traditionally, the inclusion and exclusion criteria are written in natural language in the 
protocol document. This opens for ambiguities and different interpretations among 
clinical researchers (for example, when reading the Eligibility section in a protocol 
document, it is only implicit to the reader that a patient must met ALL of the inclusion 
criteria and NONE of the exclusion criteria in order to be enrolled). 
In the OMEVAC project, the goal is to move from a paper-based way of conducting 
clinical trials to exploit the possibilities given by computers and electronic capture 
devices. One of the achievements will be patient databases and electronic medical records. 
Within this prospective, automatic patient selection based on a computerized eligibility 
criteria can reduce the resources needed to enroll patients, and possible reduce the risk of 
misinterpretation of the inclusion and exclusion criteria, which in turn can be a potential 
safety hazard for patients involved in the study. 
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APPENDIX B. EVALUATOR RESPONSES 
Evaluator 1 
Part I 
  
Strongly 
 disagree 
  Strongly 
     agree 
1. I think that I would like to use 
this system frequently 
   X  
1 2 3 4 5 
 
2. I found the system 
unnecessarily complex 
 X    
1 2 3 4 5 
 
3. I thought the system was easy 
to use 
    X 
1 2 3 4 5 
 
4. I think that I would need the 
support of a technical person 
to be able to use this system 
 X    
1 2 3 4 5 
 
5. I found the various functions 
in this system were well 
integrated 
    X 
1 2 3 4 5 
 
6. I thought there was too much 
inconsistency in this system 
X     
1 2 3 4 5 
 
7. I would imagine that most 
people would learn to use this 
system very quickly 
  X   
1 2 3 4 5 
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8. I found the system very 
cumbersome/awkward to use 
   X  
1 2 3 4 5 
 
9. I felt very confident using the 
system 
  X   
1 2 3 4 5 
 
10. I needed to learn a lot of 
things before I could get 
going with this system 
   X  
1 2 3 4 5 
 
Part II 
1. Experience with other systems 
a) I know of similar systems X 
Yes No 
 
b) I have used similar 
system(s) before 
 
X 
Yes No 
If answer is No, go to d) 
c) I have used these systems 
before: 
   
 
 
 
d) I will summarize the major 
difference between the 
system(s) I have previously 
used and this as: 
  
 
 
 
 
 
 
 
2. Technology 
a) I would like to use a system X 
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like this in my own practice Yes No 
 
b) In what ways, if any, could 
this system improve your 
current practice?  
 By forcing the eligibility criterias to be defined 
so that they can also be computerized. Some of 
them were to my knowledge very difficult to 
implement (or impossible). 
 
 
c) What potential advantages, 
if any, could the use of a 
system like this have? 
 It ensures that the protocol is adhered to  
 
 
d) What potential 
disadvantages, if any, could 
the use of a system like this 
have? 
 It may loose some of the flexibility and medical 
based decisions. 
 
 
e) How can this system be 
improved in terms of 
functionality and user 
friendliness? 
 In this setup, the major limiting factor is the fact 
that it uses the OpenMRS API, which to people 
not familiar with it, is complex. But a person 
knowing OpenMRS would very quickly be able 
to complete these steps. 
 
f) Were you able to formulate 
any tasks from your own 
practice? If not, what was 
the problem?  
  
Did not have any that I had at hand when doing 
this test. 
 
 
g) General comments, 
thoughts, etc. 
This is a very interesting project, and I look 
forward to seeing the outcomes of it.  
 
 
Evaluator 2 
Part I 
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Strongly 
 disagree 
  Strongly 
     agree 
1. I think that I would like to use 
this system frequently 
    X 
1 2 3 4 5 
 
2. I found the system 
unnecessarily complex 
 X    
1 2 3 4 5 
 
3. I thought the system was easy 
to use 
   X  
1 2 3 4 5 
 
4. I think that I would need the 
support of a technical person 
to be able to use this system 
 X    
1 2 3 4 5 
 
5. I found the various functions 
in this system were well 
integrated 
    X 
1 2 3 4 5 
 
6. I thought there was too much 
inconsistency in this system 
 X    
1 2 3 4 5 
 
7. I would imagine that most 
people would learn to use this 
system very quickly 
  X   
1 2 3 4 5 
 
8. I found the system very 
cumbersome/awkward to use 
 X    
1 2 3 4 5 
 
9. I felt very confident using the 
system 
   X  
1 2 3 4 5 
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10. I needed to learn a lot of 
things before I could get 
going with this system 
  X   
1 2 3 4 5 
 
Part II 
1. Experience with other systems 
a) I know of similar systems X 
Yes No 
 
b) I have used similar 
system(s) before 
 
X 
Yes No 
If answer is No, go to d) 
c) I have used these systems 
before: 
  OpenMRS Cohort Builder 
 
 
d) I will summarize the major 
difference between the 
system(s) I have previously 
used and this as: 
This system can search for very, very specific 
information; at a far greater depth than Cohort 
Builder.  
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2. Technology 
a) I would like to use a system 
like this in my own practice 
X 
Yes No 
 
b) In what ways, if any, could 
this system improve your 
current practice?  
It could allow clinicians in our organization to 
quickly find patients matching very specific 
criteria. This of course could expedite the entire 
process of analysis.  
 
c) What potential advantages, 
if any, could the use of a 
system like this have? 
Again, allowing one to find highly specific 
information quickly.  
 
 
d) What potential 
disadvantages, if any, could 
the use of a system like this 
have? 
Because it can be so specific, only people with 
specialized knowledge in that field could operate 
the system.  
 
 
e) How can this system be 
improved in terms of 
functionality and user 
friendliness? 
When setting conditions (ex: where [concept is 
CDC CATEGORY C] ) another window opens, 
but when setting conditions in there, yet another 
window can open, this time right on top of the 
first, making it hard to distinguish between the 
two. This should be resolved. Also, I would like 
to be able to search for terms within concept 
descriptions (ex: selecting a concept that 
contains the word “chronic” in the description). 
 
f) Were you able to formulate 
any tasks from your own 
practice? If not, what was 
the problem?  
No. I ran into connectivity problems.   
 
 
 
g) General comments, 
thoughts, etc. 
If integrated into OpenMRS (not just as a 
module), then it could easily replace the Cohort 
Builder. I liked how you can search from general 
demographics down to the most specific 
observations. 
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Evaluator 3 
Part I 
  
Strongly 
 disagree 
  Strongly 
     agree 
1. I think that I would like to use 
this system frequently 
    X 
1 2 3 4 5 
 
2. I found the system 
unnecessarily complex 
   X  
1 2 3 4 5 
 
3. I thought the system was easy 
to use 
 X    
1 2 3 4 5 
 
4. I think that I would need the 
support of a technical person 
to be able to use this system 
 X    
1 2 3 4 5 
 
5. I found the various functions 
in this system were well 
integrated 
   X  
1 2 3 4 5 
 
6. I thought there was too much 
inconsistency in this system 
X     
1 2 3 4 5 
 
7. I would imagine that most 
people would learn to use this 
system very quickly 
   X  
1 2 3 4 5 
 
8. I found the system very  X    
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cumbersome/awkward to use 1 2 3 4 5 
 
9. I felt very confident using the 
system 
   X  
1 2 3 4 5 
 
10. I needed to learn a lot of 
things before I could get 
going with this system 
   X  
1 2 3 4 5 
 
Part II 
1. Experience with other systems 
a) I know of similar systems X 
Yes No 
 
b) I have used similar 
system(s) before 
 
X 
Yes No 
If answer is No, go to d) 
c) I have used these systems 
before: 
   
 
 
 
d) I will summarize the major 
difference between the 
system(s) I have previously 
used and this as: 
  
I haven’t used such a tool before. 
 
 
 
 
 
 
2. Technology 
a) I would like to use a system 
like this in my own practice 
X 
Yes No 
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b) In what ways, if any, could 
this system improve your 
current practice?  
 It would be useful if the system could import a 
user specified dictionary so that it could adapted 
for developing Inclusion & Exclusion criteria for 
any type of selection procedure, not just in 
medicine. 
 
 
c) What potential advantages, 
if any, could the use of a 
system like this have? 
 To quickly develop selection criteria for all 
sorts of sample surveys. 
 
 
d) What potential 
disadvantages, if any, could 
the use of a system like this 
have? 
Domain-specific dictionaries should be possible 
to add to the software by the user. 
This system does not point out errors in the 
expressions. 
 
 
e) How can this system be 
improved in terms of 
functionality and user 
friendliness? 
  
It would help if the system permitted me to edit 
the Code for the expressions directly as that is 
sometimes required for better control. 
Errors in expressions should be highlighted so 
that they can be easily corrected. 
 
 
f) Were you able to formulate 
any tasks from your own 
practice? If not, what was 
the problem?  
 Not applicable 
 
 
g) General comments, 
thoughts, etc. 
 
A nice tool that could be generalized for 
developing selection criteria for a wide variety 
of applications 
 
 
Evaluator 4 
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Part I 
  
Strongly 
 disagree 
  Strongly 
     agree 
1. I think that I would like to use 
this system frequently 
     
1 2 3 4 5 
 
2. I found the system 
unnecessarily complex 
   x  
1 2 3 4 5 
 
3. I thought the system was easy 
to use 
 x    
1 2 3 4 5 
 
4. I think that I would need the 
support of a technical person 
to be able to use this system 
 x    
1 2 3 4 5 
 
5. I found the various functions 
in this system were well 
integrated 
   x  
1 2 3 4 5 
 
6. I thought there was too much 
inconsistency in this system 
   x  
1 2 3 4 5 
 
7. I would imagine that most 
people would learn to use this 
system very quickly 
 x    
1 2 3 4 5 
 
8. I found the system very 
cumbersome/awkward to use 
 x    
1 2 3 4 5 
 
9. I felt very confident using the 
  x   
1 2 3 4 5 
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system 
10. I needed to learn a lot of 
things before I could get 
going with this system 
  x   
1 2 3 4 5 
 
Part II 
1. Experience with other systems 
a) I know of similar systems x 
Yes No 
 
b) I have used similar 
system(s) before 
 
x 
Yes No 
If answer is No, go to d) 
c) I have used these systems 
before: 
   
No 
 
 
d) I will summarize the major 
difference between the 
system(s) I have previously 
used and this as: 
 NA 
 
 
 
2. Technology 
a) I would like to use a system 
like this in my own practice 
Yes No 
 
b) In what ways, if any, could 
this system improve your 
current practice?  
  
NA 
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c) What potential advantages, 
if any, could the use of a 
system like this have? 
 This system could help in ensuring that data 
collected conforms to predetermined conditions 
thereby reducing errors. 
 
 
d) What potential 
disadvantages, if any, could 
the use of a system like this 
have? 
 It might be too restrictive and inflexible for the 
end user. 
 
 
e) How can this system be 
improved in terms of 
functionality and user 
friendliness? 
 Provide more meaning and consistence to the 
fields in the system. 
 
f) Were you able to formulate 
any tasks from your own 
practice? If not, what was 
the problem?  
  
Yes 
 
 
g) General comments, 
thoughts, etc. 
More thoughts need to be given to develop a 
more user-friendly view of the data. 
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APPENDIX C. EVALUATION TASKS AND CLINICALTRIALS.GOV IDENTIFIERS 
Evaluation task 1 is compounded by single criteria from different protocols and is followed 
by the clinicaltrials.gov identifier is in parenthesis. All criteria in tasks 2 and 3 is taken from 
protocols with identifier NCT00164216 and NCT00122941, respectively. The full protocol 
document is found by searching for the identifier at http://clinicaltrials.gov/ct2/search. 
Evaluation task 1 
Inclusion Criteria: 
1.1. Males or females aged greater than or equal to 1 to less than 4 years (NCT00740090) 
1.2. Known residents of the village of Bancoumana, Mali or its surrounding area  
(NCT00740090) 
1.3. Identified as having a malaria infection by blood film examination (NCT00167739) 
Exclusion Criteria: 
1.4. Convulsions or history of convulsions (NCT00167739) 
1.5. Known hypersensitivity or allergy to artemisinin derivatives or mefloquine or 
mefloquine chemically related compounds (for example quinine and quinidine) 
(NCT00243737) 
1.6. Presence of any known serious chronic disease (e.g. AIDS, sickle cell disease, 
malignancy) (NCT00327964) 
Evaluation task 2 
All taken from NCT00164216 
Inclusion Criteria: 
2.1. Age > 1 year 
2.2. Axillary temperature ≥ 37.5ºC and/or history of fever in the previous 48 hours 
without any other evident cause 
2.3. Unmixed infection with P. falciparum of between 250 and 100,000 asexual 
parasites/mm3 as determined by microscopic exam of the thick or thin smear 
2.4. An informed consent obtained from the patient or his/her guardian (in case of 
patients ≤ 18 years old) and assent for children (8-18 years old) 
Exclusion Criteria: 
2.5. Other severe chronic diseases (e.g., cardiologic, renal, or hepatic diseases; 
HIV/AIDS; severe malnutrition) 
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2.6. History of allergy to mefloquine, artesunate, quinine, tetracycline, or clindamycin 
2.7. Pregnancy (based on urine test), since this group of patients receives other drugs for 
malaria treatment in accordance with Peruvian national guidelines. 
Evaluation task 3 
All taken from NCT00122941 
Inclusion Criteria: 
3.1. Aged 1 to 5 years 
3.2. HIV infection (previously confirmed by 2 ELISAs for children > 18 months; DNA 
PCR for those < 18 months) 
3.3. Informed consent from the parent/caretaker 
3.4. Ability to return for follow-up (lives within a radius of 15 km from hospital and 
unlikely to change residence during the course of the study) 
Exclusion Criteria: 
3.5. Children already enrolled in other studies 
3.6. Children with severe abnormalities which are likely to impair oral intake (for 
example, severe cerebral palsy) 
3.7. Severely ill children requiring urgent admission and resuscitation 
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APPENDIX D. REFERENCE SOLUTIONS AND EVALUATOR SOLUTIONS  
Evaluation task 1 
Inclusion criteria 
Reference solution 
( age is greater than or equal to 1 and age is less than 4 and addresses[ where ( 
preferred is true )]cityVillage is Bancoumana and addresses[ where ( preferred 
is true )]country is MALI (ML) and observations[ where ( concept is MALARIAL 
SMEAR )]valueCoded is POSITIVE ) 
Evaluator 1 
 ( ( age is greater than or equal to 1 and age is less than 4 ) and ( addresses[ 
where ( cityVillage is Bancaoumana and country is MALI (ML) )] ) and ( 
observations[ where ( concept is MALARIAL SMEAR )]valueCoded is POSITIVE ) )  
Evaluator 2 
 ( ( gender is M or gender is F ) and ( age is greater than or equal to 1 and age 
is less than 4 ) and ( personAddresscountry is Bancoumana or 
personAddresscountry is MALI (ML) ) and observations[ where ( concept is 
MALARIAL SMEAR )]valueCoded is POSITIVE ) 
Evaluator 3 
• ( observations[ where ( concept is PATIENT AGE and ( valueNumeric is greater 
than or equal to 1 and valueNumeric is less than 4 ) )] ) 
• ( observations[ where ( concept is MALARIAL SMEAR )] ) 
• ( observations[ where ( locationregion is Bancoumana or locationregion is 
Mali or locationregion is Neighbouring area )] ) 
Evaluator 4 
( age is greater than or equal to 1 and age is less than 4 addresses[ where ( 
cityVillage is Bancouman )]country is MALI (ML) and observations[ where ( 
concept is MALARIA, MILD or concept is MALARIAL SMEAR )]valueCoded is POSITIVE ) 
Exclusion criteria 
Reference solution 
( observations[ where ( concept is CONVULSION )]valueAsBoolean is true or 
observations[ where ( concept is ARTEMISININ HYPERSENSITIVITY OR ALLERGY 
)]valueAsBoolean is true or observations[ where ( concept is AIDS 
)]valueAsBoolean is true or observations[ where ( concept is SICLE CELL DISEASE 
)]valueAsBoolean is true ) 
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Evaluator 1 
( observations[ where ( concept is AIDS or concept is SICLE CELL DISEASE 
)]valueAsBoolean is true or ( observations[ where ( concept is AIDS or concept 
is SICLE CELL DISEASE )]valueAsBoolean is true ) or observations[ where ( 
concept is AIDS or concept is SICLE CELL DISEASE )]valueAsBoolean is true ) 
Evaluator 2 
( observations[ where ( concept is AIDS )]valueAsBoolean is true and ( 
observations[ where ( concept is AIDS )]valueAsBoolean is true or 
observations[ where ( concept is AIDS )]valueAsBoolean is true ) and 
observations[ where ( concept is AIDS )]valueAsBoolean is true ) 
Evaluator 3 
• ( observations[ where ( concept is OTHER AND UNSPECIFIED CONVULSIONS )] ) 
• ( observations[ where ( concept is ARTEMISININ HYPERSENSITIVITY OR ALLERGY or 
concept is ALLERGY TO MEFLOQUINE RELATED DRUGS )] ) 
• ( observations[ where ( concept is CHRONIC DISEASE and valueCoded is AIDS or 
valueCoded is SICKLE CELL or valueCoded is MALIGNANCY )] ) 
Evaluator 4 
( observations[ where ( concept is AIDS )]valueAsBoolean is true and 
observations[ where ( concept is AIDS )]valueAsBoolean is true and 
observations[ where ( concept is AIDS )]valueAsBoolean is false ) 
Evaluation task 2 
Inclusion criteria 
Reference solution 
( birthdateyearsSince is greater than 1 and encounters[ where ( obs[ where ( 
concept is TEMPERATURE (C) )]valueNumeric is greater than 37,5 )]obsempty is 
false and observations[ where ( concept is INFORMED CONSENT GIVEN 
)]valueAsBoolean is true and observations[ where ( concept is INFORMED CONSENT 
GIVEN )]valueAsBoolean is true ) 
Evaluator 1 
( age is greater than 1 and ( encounters[ where ( encounterDatetimehoursSince is 
less than or equal to 48 )]allObs[ where ( concept is TEMPERATURE (C) 
)]valueNumeric is greater than 37.5 ) and ( observations[ where ( concept is 
INFORMED CONSENT GIVEN )]valueAsBoolean ) and ( observations[ where ( concept is 
INFORMED CONSENT GIVEN )]valueAsBoolean is true ) ) 
Evaluator 2 
( age is greater than 1 and ( observations is true and observations is greater than 
37.5 ) or ( observations is true and observations is greater than 37.5 and 
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observations is true and observations Is before Sun Nov 30 2008 19:00:00 GMT+0100 
and observations Is after Fri Nov 28 2008 19:00:00 GMT+0100 ) or ( observations Is 
before Sun Nov 30 2008 19:00:00 GMT+0100 and observations Is after Fri Nov 28 2008 
19:00:00 GMT+0100 ) and observations ) 
Evaluator 3 
Missing 
Evaluator 4 
( age is greater than 1 and observations is greater than 37.5 and observations is 
true and observations ) 
Exclusion criteria 
Reference solution 
( observations[ where ( concept is HIV POS )]valueAsBoolean is true or 
observations[ where ( concept is RENAL DISEASE )]valueAsBoolean is true or 
observations[ where ( concept is MALNUTRITION )]valueAsBoolean is true or 
observations[ where ( concept is ALLERGY TO MEFLOQUINE RELATED DRUGS 
)]valueAsBoolean is true or observations[ where ( concept is PREGNANCY 
)]valueAsBoolean is true ) 
Evaluator 1 
( age is greater than or equal to 1 and age is less than or equal to 5 and ( 
observations[ where ( concept is INFORMED CONSENT GIVEN )]valueAsBoolean is true 
or observations[ where ( concept is INFORMED CONSENT GIVEN )]valueAsBoolean is 
DETECTED ) and observations[ where ( concept is INFORMED CONSENT GIVEN 
)]valueAsBoolean is true and ) 
Evaluator 2 
( observations[ where ( concept is URINE PREGNANCY TEST )]valueCoded and 
observations[ where ( concept is URINE PREGNANCY TEST )]valueCoded is true and 
observations[ where ( concept is URINE PREGNANCY TEST )]valueCoded is POSITIVE ) 
Evaluator 3 
Missing 
Evaluator 4 
( observations[ where ( concept is PREGNANCY )]valueAsBoolean is true 
observations[ where ( concept is PREGNANCY )]valueAsBoolean is true and 
observations[ where ( concept is PREGNANCY )]valueAsBoolean is true ) 
Evaluation task 3 
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Inclusion criteria 
Reference solution 
( age is less than 5 and age is greater than or equal to 1 and observations[ 
where ( concept is HIV POS )]valueCoded is POSITIVE and observations[ where ( 
concept is HOSPITAL DISTANCE )]valueNumeric is less than 15 and ( ( 
observations[ where ( concept is ELISA )]valueCoded is POSITIVE and 
birthdatemonthsSince is greater than 18 ) or ( birthdatemonthsSince is less than 
18 and observations[ where ( concept is HIV DNA POLYMERASE CHAIN REACTION 
)]valueCoded is DETECTED ) ) ) 
Evaluator 1 
 ( observations[ where ( concept is URINE PREGNANCY TEST )]valueCoded is true or 
observations[ where ( concept is URINE PREGNANCY TEST )]valueCoded is true or 
observations[ where ( concept is URINE PREGNANCY TEST )]valueCoded is POSITIVE ) 
Evaluator 2 
( ( age is greater than or equal to 1 and age is less than or equal to 5 ) and ( 
observations is POSITIVE and observations is POSITIVE and age is greater than 1.5 ) 
or ( observations is POSITIVE and age is less than 1.5 ) and observations and 
observations ) 
Evaluator 3 
Missing 
Evaluator 4 
( age is greater than 1 and age is less than 5 and observations[ where ( concept 
is HIV POS )]valueAsBoolean is false ) 
Exclusion criteria 
Reference solution 
( currentStudiessize is 0 or observations[ where ( concept is CELEBRAL PALSY 
)]valueAsBoolean is true ) 
Evaluator 1 
Missing 
Evaluator 2 
( studies[ where ( endDate Is after Sat Nov 29 2008 19:00:00 GMT+0100 )] and 
observations[ where ( concept is CDC CATEGORY C )]valueAsBoolean is true and 
observations[ where ( concept is CDC CATEGORY C )]valueAsBoolean is true ) 
Evaluator 3 
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Missing 
Evaluator 4 
( relationships ) 
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APPENDIX E. THE CLASSREADER LOOKUP (JAVASCRIPT) 
1    Register.Lookup.add({  
2        id: 'classreader',  
3        property: /.*/,  
4        _cache: new Hash(),  
5        getItems: function(args) {  
6            var queryString = Object.toQueryString(args)  
7            var url = 'backend/classreader?'+queryString  
8      
9            var list = this._cache.get(queryString)  
10     
11           if (list) return list  
12     
13           new Ajax.Request(url, {  
14               asynchronous: false,  
15               evalJSON: true,  
16               onComplete: function(response) {  
17     
18     
19                   var res = response.responseJSON;  
20     
21                   if (res == null || typeof res != 'object') 
console.error('Could not retrieve choices from url: '+url)  
22     
23                   list = []  
24     
25                   // Create action nodes  
26                   if (res.actions)  
27                       for (var i = 0; i < res.actions.length; i++)  
28                           list.push(ActionNode.create(res.actions[i]))  
29     
30                   // Create property nodes  
31                   if (res.properties)  
32                       for (var j = 0; j < res.properties.length; j++)  
33                           list.push(PropertyNode.create(res.properties[j]))  
34     
35                   this._cache.set(queryString, list)  
36     
37               }.bind(this)  
38           });  
39     
40           return list  
41       }  
42   }) 
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APPENDIX F. THE TYPEEXTENSIONS GROOVY CLASS 
1    import java.lang.reflect.Method  
2    import java.lang.reflect.ParameterizedType  
3    import java.lang.reflect.Type  
4      
5    /**  
6     * Created by IntelliJ IDEA.  
7     * User: Bjørge  
8     * Date: 17.okt.2008  
9     * Time: 15:08:30  
10     */  
11     
12   class TypeExtensions {  
13       private static HashMap<Class, Class> extenders = new HashMap<Class, 
Class>();  
14     
15       /**  
16        * Adding methods of extender class to the extendee class  
17        * All instances of the extendee class will have methods of the extender 
class  
18        */  
19       public static extend(Class extendee, Class extender) {  
20           extenders.put(extendee, extender)  
21           for (Method m in extender.getDeclaredMethods()) {  
22               def method = m.name  
23               extendee.metaClass."$method" << {->  
24                   extender."$method"(delegate)  
25               }  
26           }  
27       }  
113 
 
APPENDIX G. THE GETALLMETHODS METHOD 
28       /**  
29        * Returns a list of methods for extended class  
30        */  
31       public static List<Method> getAllMethods(Type clazz) {  
32           if (!clazz) return null  
33           if (extenders.containsKey(clazz))  
34               return Arrays.asList(clazz.getMethods())  
35                       .plus(Arrays.asList(extenders.get(clazz).getMethods()))  
36           else  
37               return Arrays.asList(clazz.getMethods())  
38       }  
39         
40       public static Method findMethod(Type type, String property) {  
41           Method foundMethod = (Method)getAllMethods(type).find({  
42               return (  
43                   it.name == property ||  
44                   it.name == toBeanReadMethod("get", property) ||  
45                   it.name == toBeanReadMethod("is", property)  
46               )  
47           })  
48           //println "Found: $foundMethod"  
49           return foundMethod  
50       }  
51       /**  
52        * Looks up the extender class for parameter class  
53        */  
54       public static Class getExtenderForClass(Class clazz) {  
55           return extenders.get(clazz)  
56       }  
57     
58       /**  
59        * Cleans the expression for collection operators and returns it  
60        */  
61       private static String prepareExpression(String expression) {  
62           String newexp = "";  
63           int level = 0;  
64           for (char ch : expression.toCharArray()) {  
65               if (ch == '{') level++;  
66               else if (ch == '}') level--;  
67               else if (level == 0) newexp += ch;  
68           }  
69           return newexp;  
70       }  
71       /**  
72        * Converts a bean-property to an equivalent method using prefix  
73        * Prefix would typically be either 'get', 'set' or 'is'  
74        */  
75       private static String toBeanReadMethod(String prefix, String property) {  
76           return 
prefix+property.substring(0,1).toUpperCase()+property.substring(1)  
77       }  
78     
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APPENDIX H. THE GETENDCLASS METHOD 
79       /**  
80        * Reads a property path and returns the return value of the last  
81        * corresponding get-method.  
82        */  
83       public static Type getEndClass(Type clazz, String expression) {  
84     
85           expression = prepareExpression(expression);  
86           if (expression.equals("")) return clazz;  
87           String[] exprs = expression.split("\\.");  
88     
89           for (String prop : exprs) {  
90               try {  
91     
92                   Method foundMethod = null;  
93         
94                   // If the class is a parameterized type, get the inner type  
95                   if (clazz instanceof ParameterizedType) {  
96     
97                       // This is the enclosing type  
98                       Type rawType = ((ParameterizedType)clazz).getRawType()  
99     
100                      // This is the inner type  
101                      clazz = 
((ParameterizedType)clazz).getActualTypeArguments()[0];  
102    
103                      // First, look for the property in the inner type  
104                      foundMethod = findMethod(clazz, prop)  
105    
106                      // If no matching method of enclosing type could be found,  
107                      // try to look at the enclosing type  
108                      if (!foundMethod) foundMethod = findMethod(rawType, prop)  
109                  }  
110                  else  
111                      foundMethod = findMethod(clazz, prop)  
112    
113                  if (foundMethod) clazz = foundMethod.getGenericReturnType()  
114    
115              } catch (NullPointerException e) {  
116                  println "Error: "+e  
117              }  
118          }  
119          return clazz;  
120      }  
121 } 
APPENDIX I. A VISUAL REPRESENTATIO
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APPENDIX J. EXAMPLE OF AN XML SERIALIZED EXPRESSION 
<expression modelId="org.openmrs"> 
    <group negated="false"> 
        <expressionline> 
            <properties> 
                <property name="age" datatype="numeric"/> 
            </properties> 
            <comparisonoperator id="less_than"/> 
            <value displayValue="5">"5"</value> 
        </expressionline> 
        <logicaloperator id="and"/> 
        <expressionline> 
            <properties> 
                <property name="age" datatype="numeric"/> 
            </properties> 
            <comparisonoperator id="greater_or_equal"/> 
            <value displayValue="1">"1"</value> 
        </expressionline> 
        <logicaloperator id="and"/> 
        <expressionline> 
            <properties> 
                <property name="observations" datatype="collection" 
enclosed_datatype="org.openmrs.Obs"/> 
                <property name="where" datatype="org.openmrs.Obs" 
type="listselection"> 
                    <group negated="false"> 
                        <expressionline> 
                            <properties> 
                                <property name="concept" 
datatype="org.openmrs.Concept"/> 
                            </properties> 
                            <comparisonoperator id="concept_equals"/> 
                            <value displayValue="HIV POS">"HIV POS"</value> 
                        </expressionline> 
                    </group> 
                </property> 
                <property name="valueCoded" datatype="org.openmrs.Concept"/> 
            </properties> 
            <comparisonoperator id="concept_equals"/> 
            <value displayValue="POSITIVE">"POSITIVE"</value> 
        </expressionline> 
        <logicaloperator id="and"/> 
        <expressionline> 
            <properties> 
                <property name="observations" datatype="collection" 
enclosed_datatype="org.openmrs.Obs"/> 
                <property name="where" datatype="org.openmrs.Obs" 
type="listselection"> 
                    <group negated="false"> 
                        <expressionline> 
                            <properties> 
                                <property name="concept" 
datatype="org.openmrs.Concept"/> 
                            </properties> 
                            <comparisonoperator id="concept_equals"/> 
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                            <value displayValue="HOSPITAL DISTANCE">"HOSPITAL 
DISTANCE"</value> 
                        </expressionline> 
                    </group> 
                </property> 
                <property name="valueNumeric" datatype="numeric"/> 
            </properties> 
            <comparisonoperator id="less_than"/> 
            <value displayValue="15">"15"</value> 
        </expressionline> 
        <logicaloperator id="and"/> 
        <group negated="false"> 
            <group negated="false"> 
                <expressionline> 
                    <properties> 
                        <property name="observations" datatype="collection" 
enclosed_datatype="org.openmrs.Obs"/> 
                        <property name="where" datatype="org.openmrs.Obs" 
type="listselection"> 
                            <group negated="false"> 
                                <expressionline> 
                                    <properties> 
                                        <property name="concept" 
datatype="org.openmrs.Concept"/> 
                                    </properties> 
                                    <comparisonoperator id="concept_equals"/> 
                                    <value displayValue="ELISA">"ELISA"</value> 
                                </expressionline> 
                            </group> 
                        </property> 
                        <property name="valueCoded" 
datatype="org.openmrs.Concept"/> 
                    </properties> 
                    <comparisonoperator id="concept_equals"/> 
                    <value displayValue="POSITIVE">"POSITIVE"</value> 
                </expressionline> 
                <logicaloperator id="and"/> 
                <expressionline> 
                    <properties> 
                        <property name="birthdate" datatype="date"/> 
                        <property name="monthsSince" datatype="numeric"/> 
                    </properties> 
                    <comparisonoperator id="greater_than"/> 
                    <value displayValue="18">"18"</value> 
                </expressionline> 
            </group> 
            <logicaloperator id="or"/> 
            <group negated="false"> 
                <expressionline> 
                    <properties> 
                        <property name="birthdate" datatype="date"/> 
                        <property name="monthsSince" datatype="numeric"/> 
                    </properties> 
                    <comparisonoperator id="less_than"/> 
                    <value displayValue="18">"18"</value> 
                </expressionline> 
                <logicaloperator id="and"/> 
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                <expressionline> 
                    <properties> 
                        <property name="observations" datatype="collection" 
enclosed_datatype="org.openmrs.Obs"/> 
                        <property name="where" datatype="org.openmrs.Obs" 
type="listselection"> 
                            <group negated="false"> 
                                <expressionline> 
                                    <properties> 
                                        <property name="concept" 
datatype="org.openmrs.Concept"/> 
                                    </properties> 
                                    <comparisonoperator id="concept_equals"/> 
                                    <value displayValue="HIV DNA POLYMERASE CHAIN 
REACTION">"HIV DNA POLYMERASE CHAIN 
                                        REACTION" 
                                    </value> 
                                </expressionline> 
                            </group> 
                        </property> 
                        <property name="valueCoded" 
datatype="org.openmrs.Concept"/> 
                    </properties> 
                    <comparisonoperator id="concept_equals"/> 
                    <value displayValue="DETECTED">"DETECTED"</value> 
                </expressionline> 
            </group> 
        </group> 
    </group> 
</expression> 
